Search
Tackling step therapy
Step therapy protocols interfere with your patients’ care and create unnecessary burdens on your practice. Thanks to the AADA’s advocacy efforts, dozens of states have enacted step therapy reform laws, recognizing the value of a physician’s medical judgment. ... Most recently, our work resulted in step therapy legislation in: ...
Advocacy — Step therapy win in California
California strengthens your patients’ access to care ... With your help, the AADA successfully advocated for step therapy legislation in California that would improve existing law around step therapy protocols. ... The California Assembly and Senate unanimously passed legislation that will: ... Require a shorter timeframe for insurance companies to
Step therapy legislation
Fast facts ... Step therapy is a tool used by health plans to control spending on patients' medications. ... In 2010, nearly 60% of commercial insurers were using step therapy. As of 2014, 75% of large employers reported offering employees plans that use step therapy. ... Step therapy has been
Step therapy
Step therapy is a tool used by health plans to control spending on patient medications. Typically, it requires a doctor to prescribe a cheaper alternative to the medication or treatment the doctor believes will provide best care for the patient. ... The Academy opposes step therapy and "fail first" strategies
Playing the field: Introducing tirbanibulin for actinic keratosis therapy
By Warren R. Heymann, MD January 27, 2021 Vol. 3, No. 4 Field therapy is a cornerstone of actinic keratosis (AK) management. Two years ago, a ... New England Journal of Medicine article demonstrated that 5-fluorouracil (5-FU) was the best among inadequate therapies (compared to imiquimod, MAL-PDT, and ingenol mebutate).
Advocating for you — Tackling step therapy, formulary changes
Too often, step therapy protocols interfere with your patients’ care and create unwanted burdens on your practice. ... Thanks to the AADA’s advocacy efforts, dozens of states have enacted step therapy reform laws, recognizing the value of a physician’s medical judgment. Most recently, our work resulted in strengthening the existing
Advocating for you — Step Therapy Reform
Step therapy reform making a difference for the way you practice ... Too often, step therapy protocols interfere with patient care and create unwanted burden on dermatology practices. Treatment decisions should be made between you and your patient, resting clinical authority in your hands. ... We’re advocating on behalf of
Keeping you in the driver’s seat with step therapy and prior authorization reform
Step therapy and prior authorization protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s advocacy efforts over the years, dozens of states have enacted step therapy reform laws. With more than half of the country recognizing the value of a physician’s medical judgment,
Advocating for you — Keeping you in the driver’s seat with step therapy reform
Too often, step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s advocacy efforts over the years, dozens of states have enacted step therapy reform laws. With more than half of the country recognizing the value of a physician’s medical judgment, we
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer, on prescribed anticoagulation therapy, who had intermediate layer and/or complex linear closures OR reconstruction after skin
Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid
By Warren R. Heymann, MD Oct. 7, 2020 Vol. 2, No. 40 It is not my imagination — I have been seeing more cases of bullous pemphigoid (BP) than ever. This is likely a function of an aging population in concert with an increase of drug-induced cases, notably with dipeptidyl
Keeping dermatologists in the driver’s seat with step therapy reform
Moving the needle ... By Victoria Houghton, Managing Editor, March 1, 2023 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s
Atopic dermatitis: Fantasizing about a dual approach
By Warren R. Heymann, MD March 9, 2017 Patient photos before and after dupilumab. A, Subject-provided photograph before the start of dupilumab therapy. B, Photograph taken in the clinic 1 year after the patient started dupilumab therapy. ... Credit: ... JAAD It has been acknowledged that we are on the
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
Keeping you in the driver’s seat with step therapy and prior authorization reform
Moving the needle ... By Victoria Houghton, Managing Editor, November 1, 2022 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Step therapy and prior authorization protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks
State advocacy support
Find your state society Looking to get involved at the local level? Search for your state society. ... Step therapy legislation Get the latest news on step therapy legislation that has passed in states. ... Pending state legislation Get updates on laws that are pending in state legislatures. ... State
Reporting excimer laser therapy: When to use 96999 vs 9692x
As a result of a code descriptor change for CPT codes 96920-96922 effective Jan. 1, 2024, these codes are now to be used only for excimer laser treatment of psoriasis. This change was made by the AMA CPT to better align with the intended use of these services exclusively for
Demystifying step therapy
Get familiar with the appeals process, your state’s laws, and what’s happening with reform efforts ... Feature ... By Emily Margosian, assistant editor, March 1, 2021 For many dermatologists, step therapy is an unwelcome and familiar hurdle, often requiring careful navigation of an onerous appeals process while patients fail to
Advocacy — 2021 AADA Virtual Legislative Conference
Taking your voice to D.C. ... During the second annual AADA Virtual Legislative Conference, held on Sept. 23-28, we brought some of the most vital dermatologic issues to members of Congress, and it made a difference. Notably, more than 150 of you advocated for Medicare stability and step therapy reform.
Low dose isotretinoin for recalcitrant rosacea: I pledge to use it sporadically
By Warren R. Heymann, MD June 14, 2016 While rosacea can usually be reasonably managed with a combination of topical agents (metronidazole, azelaic acid, ivermectin, sulfacetamide, brimonidine), oral antibiotics (the tetracycline family), vascular lasers, intense pulsed light and surgery (for phymatous disease), some cases are recalcitrant to standard therapy. ...
The real jigsaw puzzle of the Brooke-Spiegler Syndrome: Translating the molecular biology to therapy
By Warren R. Heymann, MD Oct. 22, 2018 Residents jump for joy when they see the characteristic "jigsaw puzzle" appearance of cylindromas under the microscope. Histopathology, however, takes us only so far. The future lies in elucidating the molecular pathways of these tumors that lead to therapy. Who could have
Share your experiences with delays or disruption to treatments
Have you experienced step therapy, prior authorization, or non-medical switching, and has it delayed you from accessing a necessary treatment? If so, the Academy wants to hear from you. The Academy advocacy team is active all year long in advocating for patients to have access to effective and affordable treatments.
Organ transplants and skin cancer risk
Due to long-term complications from immunosuppressive therapy, transplant patients face a much greater risk for melanoma, the deadliest form of skin cancer, than the general population. ... Organ transplants and skin cancer risk ... Click to view and download the infographic. ... Download Source: www.ncbi.nlm.nih.gov/pmc/articles/PMC4022534/ More information: Skin Cancer Resource
Can oral ivermectin cure pediatric periorificial dermatitis? It mite!
By Warren R. Heymann, MD March 5, 2017 A 13-year-old boy with severe rosacea before (A) and 1 month (B) and 4 months (C) after receiving oral therapy with a single dose of 250 μg/kg ivermectin (case 3). Note the facial desquamation after the first weeks of therapy, not attributable
Working to enact step therapy reform in your state
Moving the needle ... By Victoria Houghton, Managing Editor, March 1, 2022 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Too often, step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Treatment decisions
May 8, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 8, 2024 ... A review of topical treatments for AK field therapy DermWorld Insights and Inquiries : Hard questions about subcutaneous fat necrosis of the newborn and hypercalcemia Derm Coding
Highlighting the specialty in the nation’s capital
Every year, dermatologists and patient advocates come to Washington, D.C., to learn about and participate in the advocacy process by visiting with federal lawmakers. During the annual AADA Legislative Conference, held on Sept. 10-12, 2023, almost 200 attendees urged Congress to: ... Address the systemic issues within the Medicare physician
We’ve got new AK guidelines with CME credit
The AAD recently released a course to help members implement new guidelines of care for the management of actinic keratosis (AK). The on-demand, online learning will help you: ... Identify the appropriate background assessments needed before starting topical, cryosurgery, photodynamic, or combination therapy for adult actinic keratosis. ... Recognize the
Finding support for severe psoriasis
A dermatologist helps a patient with psoriasis manage his chronic condition–and navigate a complex insurance process known as step therapy. ... Joshua's story ... Joshua Rubin, patient ... For more than three decades, I’ve lived with severe psoriasis, a chronic, inflammatory skin disease that affects up to 3% of people
August 21
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 21, 2019 ... FDA grants breakthrough therapy designation to advanced melanoma treatment DW Insights and Inquiries : Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections Quality
A presidential viewpoint: “Nobody knew that benign vascular lesions of the lip could be so complicated”
By Warren R. Heymann, MD April 14, 2017 Well, maybe not as befuddling as replacing Obamacare, but there may be occasional difficulties in diagnosing benign vascular lesions of the lip, with implications for appropriate therapy. ... Tobouti et al, in a study from an oral pathology service, found that of
June 30, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 30, 2021 ... Treating atopic dermatitis with cognitive behavioral therapy: Does it work? DermWorld Insights and Inquiries : Deep learning in dermatopathology Sublingual tofacitinib for alopecia areata Biologic psoriasis treatments
Meaningful benefits — Quick coding guides
So many codes, so little time ... Not sure how to code for that insect bite or sting? We’ve got you covered. Need a photodynamic therapy code right now? We have that info too. Your Academy coding staff knows how busy you are in your practice, so we’ve developed several
PBM advocacy wins for dermatology patients
With several wins for patient access to critical medications, the AADA continues to urge pharmacy benefit managers (PBMs) and payers to improve patient access to needed treatments and challenge payer use of step therapy, formulary changes, non-medical switching, and/or payer-mandated drug substitution. ... AADA advocacy wins on behalf of members
Joining the bullae pulpit: PD-1 inhibitors
By Warren R. Heymann, MD Aug. 25, 2016 As the use of immune checkpoint inhibitors has increased, so have the number of severe immunotherapy-related adverse events (irAEs). Although discontinuation of therapy may result in resolution of these untoward reactions, long-term sequelae and death have been reported. In a recently published
Selectivity and the choice of beta-blockers for infantile hemangiomas
By Warren R. Heymann, MD Sept. 11, 2017 Clinical evolution of an infantile ulcerated hemangioma on upper lip of patient 7. Clinical appearance: Before starting propranolol (A); after 12 months of follow-up (3 months of treatment) (B). ... Credit: ... JAAD Has there ever been a more radical change in
An acne vaccine to make patients happy CAMPers?
By Warren R. Heymann, MD Nov. 12, 2018 When walking back to my office after receiving my flu shot, I thought about how wonderful it be to have a preventive therapy for common dermatologic disorders such as acne. That may not be so far-fetched. ... Acne vulgaris (referred to as
Support system
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists step in to treat cutaneous side effects of cancer treatments so patients can complete their therapy ... Dermatologists step in to treat cutaneous side effects of cancer treatments so patients can complete their therapy ... By Ruth
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection ... DESCRIPTION: Percentage of procedures in patients, aged 18 and older with a diagnosis of skin cancer, who had intermediate layer and/or complex linear closures OR reconstruction after skin cancer resection where opioid/narcotic therapy was prescribed as first
See the light in reporting phototherapy services
Derm Coding Consult ... By Cynthia Stewart, CPC, CPMA, COC, CPC-I, Manager, Coding and Reimbursement Resources, May 1, 2022 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . AAD/A Coding and Reimbursement staff have received several questions from
Eruptive nevi: Trying to connect the dots
By Warren R. Heymann, MD Sept. 15, 2016 Eruptive nevi are striking — they may appear after a variety of disorders, including Stevens-Johnson/toxic epidermal necrolysis, primary blistering diseases, trauma, immunosuppression (from disease or iatrogenically-induced), PUVA therapy, or idiopathically. There are also several reports in the literature for eruptive Spitz nevi
April 19, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 19, 2023 ... Acne scars: Low-dose oral isotretinoin monotherapy vs. combined therapy with picosecond laser DermWorld Insights and Inquiries : No longer flailing with Flegel disease Academy mourns the passing
New data to recall when considering radiation recall dermatitis
By Warren R. Heymann, MD Sept. 30, 2020 Vol. 2, No. 39 I have always been mystified by the diagnosis of radiation recall dermatitis (RRD). RRD was first described in 1959 by D’Angio et al who stated: "Actinomycin D therapy alone can reactivate ‘latent’ radiation effects in normal tissues. For
March 2, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 2, 2022 ... Biotin beware: Physician, patient knowledge about lab interference DermWorld Insights and Inquiries : The rhythm of RIME Infections in children treated with dupilumab Cutaneous adverse events are
Oncolytic virotherapy and the dermatologist
By Warren R. Heymann, MD March 8, 2018 My late British cousin Tim, a brilliant, kind, benevolent husband, father, gastroenterologist, and MBA, lost his battle with glioblastoma in 2016 at age 55.* I was hoping that he might be able to get into a trial using an oncolytic virus (OV),
March 23, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 23, 2022 ... Acitretin: A new therapy for onychomycosis? DermWorld Insights and Inquiries : A new wrinkle in the diagnosis of cystic fibrosis? Injury and litigation in cutaneous laser surgery
August 12, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 12, 2020 ... Treating trichotillomania: Beyond antidepressants DW Insights and Inquiries : Mogamulizumab for CTCL — Targeted therapy and immunotherapy crossing paths 2021 Medicare fee schedule rewards cognitive work, but
What's hot?
What's hot ... May 31, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... There are several FDA-approved options available for field therapy for the treatment of multiple actinic keratoses, including
January 11, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 11, 2023 ... Antihistamines as adjunct therapy for alopecia areata DermWorld Insights and Inquiries : Acquisition and loss — A tribute to Jouni Uitto, MD, PhD Lidocaine shortage: Ask the
More than 200 AADA members, patients ask Congress to halt Medicare payment cuts, reform step therapy
Facts at your fingertips ... By Emily Margosian, Assistant Editor, January 1, 2022 The second annual AADA Virtual Legislative Conference again saw impressive participation numbers this past September, bringing key dermatologic issues before members of Congress. Attendees included physicians, residents, select medical students, dermatology nurses, and patient advocates. ... Participating
Oral tranexamic acid to treat melasma: Are you bloody kidding me?
By Warren R. Heymann, MD Aug. 1, 2016 Tranexamic acid (TA) is a synthetic derivative of lysine utilized as an antifibrinolytic agent to prevent bleeding (for dental surgery in patients with hemophilia, post-cardiac bypass surgery patients, or in women with menorrhagia) and as a treatment option for hereditary angioedema.
An uphill battle
Pediatric dermatologists share struggles and successes obtaining treatments for their patients ... Feature ... By Allison Evans, Assistant Managing Editor, December 1, 2021 In a perfect world, a dermatologist would diagnose their patient’s condition and prescribe a therapy, and the patient would receive treatment. Unfortunately, in reality, dermatologists diagnose a
The ironclad promise of ferroptosis
By Warren R. Heymann, MD, FAAD Jan. 25, 2023 Vol. 5, No. 4 As checkpoint inhibition of programmed cell death protein 1 (PD1) has become standard oncologic therapy, it is easy to forget that this revolutionary therapy is barely a decade old. Until 1972, cell death was considered passive and
Topical retinoid therapy for acanthosis nigricans: In the thick of it
By Warren R. Heymann, MD Dec. 11, 2019 Vol. 1, No. 39 At the risk of overgeneralizing, in my experience there are two types of patients with acanthosis nigricans (AN) — those who are devastated by it, and those are unaware that they have it. ... This commentary will focus
December 4, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 4, 2024 ... What’s the best treatment for squamous cell carcinoma in situ? DermWorld Insights and Inquiries : Darier disease is rough clinically and therapeutically. MEK inhibition may offer a
COVID’s impact on cosmetic procedures
Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release
Can chimeric antigen receptor T cells trigger long-term remission of autoimmunity?
Acta Eruditorum ... Dr. Van Voorhees is the physician editor of ... Dermatology World . She interviews the author of a recent study each month. ... By Abby S. Van Voorhees, MD, January 1, 2018 In this month's Acta Eruditorum column, Physician Editor Abby S. Van Voorhees, MD, talks with
AAD Prior Authorization Appeal Letter Tool
{{ steps[index] }} ... Step {{index + 1}} of {{steps.length}} ... Dermatologic disease with ICD-10 diagnosis code ... Name of drug ... Alternative treatment drug options ... For step therapy protocols, select drug/treatment the insurance company is requiring you to prescribe your patient as an alternative treatment (skip if not
Patient advocate resources
Academy advocacy & patient education resources ... Advocacy priorities ... Online public education on diseases and conditions Prior authorization patient resources Drug pricing and availability Step therapy legislation Patient power ... Read the ... DermWorld feature ... Patient Power: Technology amplifies the patient voice in advocacy groups . ...
January 27, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 27, 2021 ... Can dermatology employers require employees to receive the COVID-19 vaccine? DermWorld Insights and Inquiries : Playing the field — Introducing tirbanibulin for actinic keratosis therapy DermWorld Young
February 21, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 14, 2024 ... Treating keloids, hypertrophic scars with dupilumab DermWorld Insights and Inquiries : Alaskapox — The beat goes on Cosmetic dermatologic procedures performed by physicians vs. non-physicians FDA approves
July 6, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 6, 2022 ... Long-term recurrence rates of actinic keratoses DermWorld Insights and Inquiries : Isotretinoin and diabetes — Of familiarity and surprise What physicians should know about monkeypox Anti-PD-1 therapy
Calcipotriene and 5-fluorouracil: Dermatology’s new dynamic duo?
By Warren R. Heymann, MD Sept. 18, 2019 Vol. 1, No. 28 Chatting with my chief resident, Tia Pyle, I was lamenting the recent comparative report that ingenol mebutate (and other treatments) did not fare as well as 5-fluorouracil (5-FU) for treating actinic keratoses (AKs). (1) (See previous ... Dermatology
July 26, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 26, 2023 ... Intralesional HPV vaccine may clear recalcitrant warts DermWorld Insights and Inquiries : Cycling back to doxycycline’s roots as therapy for bullous pemphigoid FDA approves first molluscum contagiosum
Guidance on the use of immunosuppressive agents
The Academy strongly recommends that patients should not stop their ongoing systemic immunosuppressive therapy without consulting their physicians. To better serve patients and their physicians, the Academy has created interim recommendations on the use of immunosuppressive agents and spironolactone during COVID-19, available below. ... See the full guidance ... See
When cancer treatment leads to vitiligo
A dermatology-oncology collaboration helped a patient avoid choosing between skin disease and cancer treatment. ... Shawn's story ... Shawn Bruton, patient ... I didn’t expect my cancer treatment to damage my skin. ... Three years after my lung cancer diagnosis, discolored patches appeared on my stomach, arms, and legs. My
March 7
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / MARCH 7, 2018 ... Is MIPS a burden? Tell CMS and get full credit in 2018. Academy election results announced ABD requests Mohs subspecialty certification AAD relocates headquarters Conversion therapy still
March 11, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 11, 2020 ... A guide to managing coronavirus in dermatology clinics DW Insights and Inquiries : The 2020 vision for nemolizumab in atopic dermatitis Feedback requested: AAD/NPF draft guidelines for
Cutting giant congenital nevi down to size molecularly
By Warren R. Heymann, MD Oct. 2, 2019 Vol. 1, No. 30 Personally, I find giant congenital melanocytic nevi (GCMN) to be among the most unnerving skin lesions imaginable. The risk of melanoma, leptomeningeal melanocytosis, and psychosocial stresses are profoundly burdensome to patients, their families, and health care professionals. With
Can topical ketoconazole tip the scales for acne vulgaris?
By Warren R. Heymann, MD Oct. 21, 2020 Vol. 2, No. 42 "Now trending." How often have you seen that phrase when you go online? When it comes to trends in treating acne vulgaris (AV), despite the new addition of oral sarecycline and the release of topical minocycline foam, there
May 29
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 29, 2019 ... Academy issues statement on sunscreen safety DW Insights and Inquiries : Life is just a bowl of cherry angiomas AccessDerm: Serving the underserved Anthem enforces modifier 25
March 24, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 24, 2021 ... Derm Coding Consult : Applying 2021 E/M coding concepts in everyday practice — Part 1 DermWorld Insights and Inquiries : Lipschütz ulcers — Not only for women
April 28, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 28, 2021 ... Acne: Clindamycin-tretinoin vs. benzoyl peroxide-adapalene DermWorld Insights and Inquiries: Do not get burned by missing Staphylococcal scalded skin syndrome Is daylight photodynamic therapy effective for actinic keratosis?
Advocating for you — Highlighting the specialty in the nation’s capital
The messages you delivered to members of Congress in 200+ virtual meetings did not go unnoticed, and had a direct impact on legislation that affects you and your patients. ... Every year, dermatologists and patient advocates come to Washington, D.C., to advocate on the specialty’s priorities. During the second annual
February 5, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 5, 2020 ... Legislators aim to prevent sunscreen bans DW Insights and Inquiries : Prurigo pigmentosa as the "keto rash": I’m a believer Correction issued to pediatric psoriasis treatment guidelines
Sirolumus’s merit for the Kasabach-Merritt phenomenon
By Warren R. Heymann, MD Oct. 8, 2018 KHE patient after 15 months of sirolimus therapy. ... Credit: ... JAAD Thrombopenic purpura associated with benign hemangioma is rare. In fact, we have not been able to find a record of a combination of these two conditions in the medical literature.
Lagging ahead: LAG-3 checkpoint inhibition for advanced melanoma
By Warren R. Heymann, MD, FAAD May 11, 2022 Vol. 4, No. 19 Checkpoint inhibition has revolutionized the treatment of advanced melanoma over the past decade, beginning with the release of the anti-CTLA4 checkpoint inhibitor ipilimumab (Yervoy). This was followed by the development of the anti-PD-1 inhibitors pembrolizumab (Keytruda) and
May 10, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 10, 2023 ... Is spironolactone use for acne associated with increased risk for venous thromboembolism? DermWorld Insights and Inquiries : PRAME sets its eyes on the road to fame How
Progress in pemphigus: Solidifying rituximab’s role
By Warren R. Heymann, MD, FAAD July 7, 2021 Vol. 3, No. 27 "Now what do I do?" ... That question, asked by dermatologists every day about patients who are not responding to therapy, was posed in the preface of the first (and every subsequent) edition of ... Treatment of
June 26
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 26, 2019 ... CMS/NCCI changes to PTP edits go into effect next week DW Insights and Inquiries : Conceptualizing atypical fibroxanthomas, pleomorphic dermal sarcomas, and undifferentiated pleomorphic dermal sarcomas Beyond
JAMA Dermatology
Life is just a bowl of cherry angiomas Breaking the terbinafine laboratory habit for onychomycosis Coughing up a new warning for ustekinumab The rosy reality of coffee The real jigsaw puzzle of the Brooke-Spiegler Syndrome: Translating the molecular biology to therapy Old stains leaving new marks in dermatology A future
Taking biologics to heart
By Warren R. Heymann, MD Oct. 16, 2016 Comorbidities related to psoriasis have dominated the dermatologic literature for more than a decade since Joel Gelfand published his seminal paper (1). In my 2008 commentary for ... Dialogues in Dermatology , I stated that "It remains to be determined if treating
January 24, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 24, 2024 ... Micrographic vs. conventional excision: Reducing rates of BCC, SCC DermWorld Insights and Inquiries : Senile gluteal dermatosis — The term ‘senile’ is getting old and should be
Social media skin care trends: Dermatologists reveal the facts
Board-certified dermatologists provide tips for healthy skin ROSEMONT, Ill. (Oct. 29, 2024) — With the growing popularity of beauty influencers and viral skin care routines, social media is playing an integral role in shaping how people care for their skin. Popular trends like the glass-skin look, the Russian manicure, and
Can tocilizumab deep six recalcitrant morphea?
By Warren R. Heymann, MD, FAAD Sept. 20, 2023 Vol. 5, No. 38 Glenda’s middle-aged ankles still hurt badly. I have been treating morphea enveloping her ankles for several years. With therapies including methotrexate, mycophenolate mofetil, clobetasol, calcipotriene, and physical therapy, her tenderness has improved from exquisite to barely tolerable.
December 20, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 20, 2023 ... Surgical excision vs. 5-FU vs. PDT in treating Bowen’s disease DermWorld Insights and Inquiries : Holiday Greeting 2023 Association between JAK inhibitors and acne Risk of mortality
Increasing evidence for the use of topical timolol for pyogenic granulomas
By Warren R. Heymann, MD May 16, 2016 There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion. Certainly there are times when that approach may not be optimal, such as a PG the face of
This month's news from across the specialty
What's hot ... March 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD If we can get ahead of the variants through testing and new treatment regimens, we should be able
Psoriasis clinical guideline
Psoriasis is a chronic, inflammatory multisystem disease, which affects up to 3.2% of the U.S. population. The guideline is based on current evidence, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients about benefits as well as risks that may be associated. ... Psoriasis guideline
Seeing eye to eye
Go to AAD Home ... Go to AAD Home ... Menu ... When insurance doesn't cover standard of care treatments, who pays the price and what can be done about it? ... When insurance doesn't cover standard of care treatments, who pays the price and what can be done about
Learning module: Dermatologic therapies
Goals and objectives ... The purpose of this module is to help medical students gain familiarity with common dermatologic treatments. ... After completing this module, the learner should be able to: ... Estimate the amount of topical medication needed for therapy based on frequency of application and body surface area
May 11, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 11, 2022 ... Sexual dysfunction associated with finasteride use in men with androgenetic alopecia DermWorld Insights and Inquiries : Lagging ahead — LAG-3 checkpoint inhibition for advanced melanoma FDA grants
September 25, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 25, 2024 ... Cyclosporine vs. dupilumab vs. methotrexate for patients with AD DermWorld Insights and Inquiries : The expanding horizon of anti-IL-36 therapy FDA approves new treatment for immune-mediated vasculitis
I have questions about coding for contact dermatitis. Does the Academy have any resources to help?
Asked and Answered ... March 1, 2022 Yes. The Academy offers a selection of quick coding guides covering a variety of topics, including contact dermatitis. The Contact Dermatitis Quick Coder has been recently updated to reflect new 2022 codes for irritant contact dermatitis due to contact with body fluids. ...
Resident Quality Improvement Award project presentations 2022
The recipients of the 2022 Resident Quality Improvement Award present their quality improvement projects. ... Improving Quality of Care for Spanish-Speaking Patients in a Dermatology Clinic ... Afton Metkowski, MD ... Vaccination Rates in Patients on Biologic Therapy ... Carolyn Opene, MD ... Using DataDerm For Custom QI Metrics Challenges
Becoming whipped up over flagellate dermatoses
By Warren R. Heymann, MD ... July 13, 2017 ... A, A 44-year-old male patient with characteristic flagellate dermatitis after ingestion of shiitake. B, Same patient 4 days after balneo PUVA therapy. ... Credit: ... JAAD The literature on flagellate dermatoses has been whipped into frenzy. The initial description
Dermatopathology
Cutting giant congenital nevi down to size molecularly Eosinophilic dermatosis of hematologic malignancy: Reality bites Oy, another "Oid" to worry about: Cryptococcoid lesions Biting my nails worrying about atypical presentations of nail unit melanomas Deep penetrating thoughts about deep penetrating nevi Sophie’s choice: Assessing atypical Spitz tumors in the molecular
Applying the 2021 E/M coding concepts in everyday practice – Part 7
Part seven of the AADA’s clinical vignettes focuses on the application of coding concepts related to E/M encounters. These clinical vignettes demonstrate how, a common dermatologic condition, actinic keratosis in these examples, can be categorized under different categories of problem addressed during the encounter depending on disease severity and patient
Avascular necrosis in psoriasis: Avoiding “snap” judgments
By Warren R. Heymann, MD May 8, 2017 Of all the adverse reactions of corticosteroids, there is none more terrifying than avascular necrosis (AVN, aka osteonecrosis); this usually involves the femoral head (AVN of the hip), although the shoulders and knees may be affected. It is estimated that 25,000 new
No one left out in the code
We’re watching out for you and want you to be at the top of your game when it comes to coding. As Academy members, ... Derm Coding Consult and ... DermWorld provide you with the latest information about accurate diagnostic and procedural coding, as well as Medicare reimbursement issues in
October 23, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein
New treatments for HIV and other STIs provide hope for better quality of life
Dermatologist discusses emerging treatments in LGBTQ+ healthcare SAN DIEGO (March 8, 2024) — LGBTQ+ individuals have unique skin care needs, including concerns about sexually transmitted infections (STI), like HIV, as well as acne and hair growth and removal, especially relating to hormone replacement therapy. With over 14 million U.S. adults
Probing pediatric pigmented purpuras
By Warren R. Heymann, MD, FAAD October 20, 2021 Vol. 3, No. 42 Pigmented purpuric (PP) eruptions are often referred to as "benign" pigmented purpuras. Although that may be true in the medical sense, these dermatoses may be very distressing for patients (or their parents). Angst may be due to
January 18, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 18, 2023 ... Have cutaneous manifestations of COVID-19 changed during Delta, Omicron waves? DermWorld Insights and Inquiries : Complications of silicone injections – persistence, stigma, and treatment AAD releases updated
Harry Nevus: A dermatologist's best friend
In Practice ... Wm. Philip Werschler, MD, FAAD, FAACS, is a dermatologist in private practice in Spokane, Washington. ... By Emily Margosian, May 1, 2018 He’s one “hairy” nevus patients are happy to see. The aptly named Sir Harry Nevus, resident pug and certified therapy animal, is one of Spokane
November
Issue ... November January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... A time for thanks What’s hot ... This month’s news from across the specialty Clinical Applications ... Do tumor-infiltrating lymphocytes predict melanoma outcomes? Feature
October 26, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 26, 2022 ... Diagnosing and treating onychomycosis DermWorld Insights and Inquiries : Lending a helping hand to our patients with Dupuytren’s disease GoodRx launches provider-facing tool for point-of-care savings Distinguishing
A slippery slope
Non-physician providers seek authority to perform cosmetic medical procedures, threatening patient safety and the value of specialty medical training ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2022 The Academy has been monitoring and responding to a variety of proposals and bills in the aesthetic arena that
Clinical guidelines disclaimer
DISCLAIMER Adherence to these guidelines will not ensure successful treatment in every situation. Furthermore, these guidelines should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. The
August 28, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 28, 2024 ... Is the oral contraceptive pill associated with frontal fibrosing alopecia? DermWorld Insights and Inquiries : Advances in therapy for the Cronkhite-Canada syndrome have increased survival — And
Learning module: HIV dermatology
Goals and objectives for module ... The purpose of this module is to help medical students develop a clinical approach to the evaluation and initial management of HIV-positive patients presenting with skin disease. ... After completing this module, the learner should be able to: ... Identify and describe the morphology
A hot year, but plenty of code, too
Because you appreciate it, we continue to add to our coding resources. ... Since the last ... Impact Report , we developed a number of resources on new topics, including the following: ... CMS releases 2024 first and second quarter NCCI edits Hot coding topics from the field Measuring a
Anticoagulants in dermatology
Dermatologists discuss perioperative management of patients on anticoagulant therapy ... Feature ... By Allison Evans, Assistant Managing Editor, June 1, 2022 Writing a script for an anticoagulant is not something dermatologists typically do, although these medications play an important role in clinical and surgical practice. The anticoagulant world has advanced
June 12, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 12, 2024 ... Acne in pregnancy: The safest options DermWorld Insights and Inquiries : CXCR4 antagonist therapy based on a WHIM syndrome Nonsteroidal approaches for treating patients with atopic dermatitis
July 1, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 1, 2020 ... Derm Coding Consult : E/M coding — What has changed? DW Insights and Inquiries : Spironolactone — An increasingly recognized hero in acne therapy Is it ethical
December 11, 2019
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 11, 2019 ... Physician depression increases medical errors…increasing depression DW Insights and Inquiries: Topical retinoid therapy for acanthosis nigricans — in the thick of it MIPS: What you need to
October 7, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 7, 2020 ... The costs of prior authorizations in a dermatology department DermWorld Insights and Inquiries : Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid
Advocacy Update May 21, 2024
IN THIS ISSUE / May 21, 2024 President Desai to testify at U.S. House hearing on impact of declining Medicare physician payments AADA honors champions of Medicare Physician Payment Reform AADA hosts 10th annual skin cancer check on Capitol Hill AADA and DermCAC urge Palmetto to change Superficial Radiation Therapy
Pediatric dermatology
Finding Joy in pediatric phototherapy Congenital Juvenile Xanthogranulomas: Born To Be Wild (But Ultimately Mild) Sophie’s choice: Assessing atypical Spitz tumors in the molecular era The real jigsaw puzzle of the Brooke-Spiegler Syndrome: Translating the molecular biology to therapy Sirolumus’s merit for the Kasabach-Merritt phenomenon A future therapeutic Harlequin Romance?
March 18, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 18, 2020 ... CMS offers physicians flexibility during COVID-19 emergency DW Insights and Inquiries : The profound dermatological manifestations of COVID-19 Feedback requested: AAD/NPF draft guidelines for the management and
What's hot?
What's hot ... March 27, 2018 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... Alopecia areata is frustrating to patients, parents, and practitioners, all of whom may be left with unsatisfactory
Prior authorization’s growing footprint
Facts at your fingertips ... By Emily Margosian, assistant editor, June 1, 2020 While prior authorization requirements have existed since the 1980s, the policy’s impact on physicians, patients, and the larger health care system has evolved considerably over the past four decades. "Physicians expect challenges when prescribing newer specialty drugs,
AADA members and their patients bring key dermatologic issues to the Hill
The Academy’s advocacy power comes from the voices of our members. At the Academy, we make it easy for your voice to be heard on the issues that matter most to your patients and practices. This year, the AADA Legislative Conference returned in-person to Capitol Hill, giving dermatologists the opportunity
Quick coding guides
Download these coding tip sheets for practical guidance on common coding. All of the links are PDFs. ... ICD-10 tip sheets ICD-10-CM Quick Coder Contact Dermatitis Quick Coder Insect Bites and Stings Quick Coder E/M coding tip sheet E/M Quick Coder Ancillary checklists Definitions for the MDM Elements Terminology CPT
VisualDX
The AAD has partnered with VisualDx to bring AAD members the award-winning diagnostic clinical decision support app that improves diagnostic accuracy, saves time, and engages patients. ... Order now VisualDx combines expert medical knowledge, standardized terminology, and quality medical images to deliver concise and accurate answers in seconds! Covers more
Derm Coding Consult
Derm Coding Consult provides Academy members with the latest information about accurate diagnostic and procedural coding, as well as Medicare reimbursement issues in dermatology. ... Latest articles ... Reporting excimer laser therapy Learn more about the code descriptor change for CPT codes 96920-96922. ... CMS creates code for treating molluscum
Medical dermatology
Topical retinoid therapy for acanthosis nigricans: In the thick of it Rituximab and dermatomyositis: Dr. Samitz would be proud The naked truth about total body skin examination: A lesson from Goldilocks and the Three Bears Getting the gist of GIST cutaneous hyperpigmentation disease I never wanted chaperones — until now
Demodectic eruptions: More than you mite have imagined
By Warren R. Heymann, MD, FAAD April 26, 2023 Vol. 5, No. 17 Despite the ongoing debate about the precise role of Demodex in the pathogenesis of multiple dermatoses (pityriasis folliculorum, papulopustular and granulomatous rosacea, perioral dermatitis, seborrheic dermatitis, blepharitis, and others), few would argue about the association of the
Dupilumab’s conjunctivitis conundrum
By Warren R. Heymann, MD June 11, 2018 Having worn glasses since kindergarten, and being virtually helpless without them, I am particularly sympathetic to patients with eye disorders. ... Ocular disease in atopic dermatitis (AD) may manifest in a variety of ways. Conjunctivitis, a predisposition to keratoconus, and anterior subcapsular
Additional boards resources
Looking for more study tools? Residents and Fellows Committee members have recommend the following resources when preparing for the boards. If there is a resource that is not on this list that you would like to recommend, please send an email to ... residents@aad.org . ... Browse dermatology books, quiz
Monitoring infantile hemangiomas: What’s the score?
By Howard B. Pride, MD, FAAD Geisinger Medical Center, Department of Dermatology Aug. 11, 2021 Vol. 3, No. 32 Infantile hemangiomas (IH) are common vascular tumors that generally run a self-limited course of rapid growth in the first 2-3 months of life, slow growth for another 4-6 months, and then
PS-Superficial Radiation Therapy
Council on Science and Research Reviewed: 11/6/2021 Position Statement on Superficial Radiation Therapy
Journal of Investigative Dermatology
Cutting giant congenital nevi down to size molecularly I never wanted chaperones — until now An acne vaccine to make patients happy CAMPers? The rosy reality of coffee Aha! The iodide paradox now makes sense! A future therapeutic Harlequin Romance? A string of (clinical) pearls about drug-induced linear IgA disease
2019 DW Insights and Inquiries archive
Explore Dermatology World Insights and Inquiries articles by publication date. ... December ... December 18 - DWI&I holiday greeting 2020: Eyeing dermatology’s future December 11 - Topical retinoid therapy for acanthosis nigricans: In the thick of it December 4 - Beware: Discordance abounds among pathologists in the diagnosis of melanocytic
This month’s news from across the specialty
What’s hot ... September 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD A novel genetic study that maps mutations in successive stages of cutaneous squamous cell carcinoma (cSCC) in mice
Elmer Fudd beware: Tularemia’s re-emergence
By Warren R. Heymann, MD Sept. 24, 2018 Ulcer on left thumb of patient with ulceroglandular tularemia. ... Credit: ... JAAD Practicing dermatology is humbling business. I tip my hat to Polat et al, who diagnosed tularemia in an 11 year-old girl presenting with targetoid papules and plaques of her
September 23, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 23, 2020 ... Nail manifestation and COVID-19: The red half-moon sign DermWorld Insights and Inquiries : The profound dermatologic manifestations of COVID-19: Part VII — Who was that masked man?
Leishmania episode 1a: attack of the clones
By Kiran Motaparthi, MD February 10, 2021 Vol. 3, No. 6 Cutaneous leishmaniasis (CL), although not life-threatening, can progress to a disfiguring disease with prominent scarring. Humans serve as reservoirs for > 20 species of ... Leishmania, which are transmitted as flagellate promastigotes by sandflies. Within humans, the organisms convert
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
International Journal of Dermatology
Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections Stress2 + Hormones2 = Acne2 Dermatologists will increasingly meet mammalian meat allergy Dermatologists cannot be lax about acquired cutis laxa A potentially life-threatening association of autoimmune blistering disease we bloody well need to be aware of: Acquired The
Pseudomolluscoid papules: A more accurate description than pseudoverrucous papules
By Warren R. Heymann, MD April 28, 2016 When patients ask me how I made their diagnosis so quickly, I politely tell them that if any particular lesion takes more than 25 milliseconds to diagnose, they really do have a problem. ... Today I saw a patient that made me
April 20, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 20, 2022 ... Which biologics are most effective for psoriasis? DermWorld Insights and Inquiries : One Toker over the line — Clarifying Toker cell hyperplasia in Zuska disease and its
Doxycycline as prophylaxis for EGFR-induced folliculitis: Is a pound of cure worth an ounce of prevention?
By Warren R. Heymann, MD May 23, 2016 Epidermal Growth Factor Inhibitors (EGFRI) may cause acneiform eruptions that characteristically appear within a few weeks of their administration. These appear in > 50% of cases treated with EGFRI and in up to 100% of those cases treated with cetuximab. The appearance
Warts and all
Remedies for warts abound, but high-quality studies are lacking. ... Feature ... By Jan Bowers, contributing writer, March 1, 2021 Warts, one of the most common skin disorders worldwide, can be easy to treat or maddeningly difficult. Although warts can resolve spontaneously, others readily respond to over-the-counter treatments such as
This month's news from across the specialty
What's hot ... April 1, 2020 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... MALLORY ABATE, MD Interested in some patch testing pearls for your patients with allergic contact dermatitis? In the January issue of ...
January 3, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 3, 2024 ... Efficacy of minoxidil for cancer treatment–induced hair loss DermWorld Insights and Inquiries : Malignant syphilis — History in the making Most effective medications for plaque psoriasis Cardiovascular,
Choosing wisely: Recommendations about treatments, tests, and procedures
The ABIM Foundation’s Choosing Wisely ... ® ... campaign is focused on encouraging physicians and patients to talk about medical tests and procedures that may be unnecessary, and in some instances, can cause harm. To join, a medical society must provide expert guidance on five medical tests or treatments commonly used in its field.
March 6
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 6, 2019 ... FDA approves self-injection of guselkumab for plaque psoriasis Nearly 80% of public find drug prices 'unreasonable' Biotin supplementation unnecessary for most patients, may lead to misdiagnosis Why
DI&I encore: Better than a back scratcher?
By Warren R. Heymann, MD March 30, 2017 The potential toxicity of the combination of topical ketamine/amitriptyline/lidocaine (TKAL) was discussed in a recent entry detailing the encephalopathic findings in an octogenarian Parkinsonian man with atopic dermatitis who was treated with the compound. I concluded: "As our therapeutic options for recalcitrant
PDF of Photodynamic Therapy Quick Coder.
the procedure CPT WHO MAX PROVIDER REQUIREMENTS DESCRIPTION CODE PERFORMS UNITS (DURING THERAPY
What's hot?
What's hot ... January 2, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Many dermatologists still check baseline labs prior to prescribing oral terbinafine or griseofulvin for adults and children with dermatophyte
August 7, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 8, 2024 ... Is oral minoxidil safe for pediatric patients? DermWorld Insights and Inquiries : Rounds on pityriasis rotunda Contact allergens in ‘clean’ children’s products Is cumulative methotrexate associated with
Life is just a bowl of cherry angiomas
By Warren R. Heymann, MD May 29, 2019 Vol. 1, No. 13 "Dr. Heymann, I’ve noticed a number of these spots appearing lately." ... "They’re called cherry angiomas — totally benign." ... "Why I am getting them?" ... "Maturity." ... "You mean I’m getting old!" ... "I did not say
March 13, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 13, 2024 ... Men with androgenetic alopecia may benefit from platelet-rich plasma DermWorld Insights and Inquiries : Coming clean on chlorhexidine-induced dermatoses Roflumilast for the treatment of seborrheic dermatitis Potential
The 2020 vision for nemolizumab in atopic dermatitis
By Warren R. Heymann, MD March 11, 2020 Vol. 2, No. 10 Over the past decade, I have noticed an inversion of the ratio of patients with severe psoriasis versus atopic dermatitis (AD) in my practice. The biologic revolution has clearly favored those afflicted with psoriasis; although dupilumab has improved
Positively perplexing: Determining the meaning of CD30 positivity
By Warren R. Heymann, MD, FAAD Sept. 29, 2021 Vol. 3, No. 39 I’ll wager that most readers of DWI&I have experienced receiving a biopsy report, obtained from an inflammatory lesion, stating "scattered CD30+ cells were observed," accompanied by a comment that "clinicopathologic correlation is necessary to rule out the
PS-Red Light Therapy at Tanning Salons
OWNER: Science and Quality Position Statement on Red Light Therapy at Tanning Salons \(Approved by
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
Mogamulizumab for CTCL: Targeted therapy and immunotherapy crossing paths
By Ellen Kim , MD August 12, 2020 Vol. 2, No. 32 Preserving the host-immune system for as long as possible has been one of the guiding principles for me in treating patients with mycosis fungoides/Sezary Syndrome (MF/SS) subtypes of CTCL. As a CTCL clinical trial researcher, it has been
Anticipating Iceland: Ice-pack dermatosis
By Warren R. Heymann, MD, FAAD April 10, 2024 Vol. 6, No. 15 Iceland beckons. Many of our plans were scuttled by COVID-19, including a long-planned tour of Iceland, which (as of this writing) is exactly two months away.* My wife and I eagerly await the other-worldly topography, unpronounceable waterfalls,
Rituximab therapy for recalcitrant dermatitis herpetiformis: A gut feeling
By Warren R. Heymann, MD March 20, 2017 Dermatitis herpetiformis. Grouped papulovesicles with excoriations on the extensor surface of the shoulder. ... Credit: ... JAAD Recently I "accidentally" diagnosed a severely pruritic man with dermatitis herpetiformis (DH). He had seen leading authorities for his life-altering pruritic dermatosis, that clinically and
The expanding horizon of anti-IL-36 therapy
By Warren R. Heymann, MD, FAAD Sept. 25, 2024 Vol. 6, No. 39 An abridged version of this commentary was published in "A Clinician’s Perspective" in the April 2024 issue of the JAAD ... . We last explored the relationship between IL-36 and generalized pustular psoriasis (GPP) and the use
The journey of focal dermal hypoplasia: From description to inspired therapy
By Warren R. Heymann, MD Oct. 9, 2017 The dermatologic community lost a giant in 2014 with the passing of Robert W. Goltz, MD at the age of 90. Dr. Goltz was not only responsible for describing focal dermal hypoplasia (FDH), but also multicentric reticulohistiocytosis, generalized elastolysis, and the nevoid
Shades of Shelley: Azithromycin therapy for erythema annulare centrifugum
By Warren R. Heymann, MD April 12, 2018 The front (A1) and back (A2) portions of his upper thigh show signs of severe Erythema Annulare Centrifugum. ... Credit: ... JAAD When I first arrived in Philadelphia in 1984 for my dermatopathology fellowship at the University of Pennsylvania, the most exciting
Cycling back to doxycycline’s roots as therapy for bullous pemphigoid
By Warren R. Heymann, MD, FAAD July 26, 2023 Vol. 5, No. 30 Patients with moderate to severe bullous pemphigoid are usually treated with systemic corticosteroids. Four patients were treated with tetracycline hydrochloride and niacinamide because of the steroid-sparing anti-inflammatory properties of these agents. An excellent clinical response free of
CXCR4 antagonist therapy based on a WHIM syndrome
By Warren R. Heymann, MD, FAAD June 12, 2024 Vol. 6, No. 24 Emelio* had a delightfully whimsical personality that matched his syndrome’s acronym — WHIM ( ... W arts, ... H ypogammaglobulinemia, ... I nfections, and ... M yelokathexis). His smile was as infectious as his verrucae, and he
Incretin-based therapy for diabetes and dermatology: Promise and peril
By Warren R. Heymann, MD Oct. 23, 2017 In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes. ... Incretin hormones refer to
Drug pricing and prior authorization
Discover resources on insurance and drug pricing issues, including tools to generate prior authorization and other appeal letters for patients. ... Private payer contracts Use our resources on payer contracts to spot concerning language and negotiate for better alternatives. ... Private payer resources Access Academy resources on navigating issues with
Topical isotretinoin for ichthyoses: Striving for an “A” grade
By Warren R. Heymann, MD, FAAD Nov. 20, 2024 Vol. 6, No. 47 Two meaningful events changed my life in 1982 — my marriage and the introduction of isotretinoin. Forty-two years later, both remain front and center. Attending the focus session "Think like an expert about ichthyosis" at the AAD
Spironolactone: An increasingly recognized hero in acne therapy
By David A. Wetter, MD July 1, 2020 Vol. 2, No. 26 In 1983, Bonnie Tyler released the catchy and powerful anthem, "Holding Out for a Hero." Emotion exudes from the lyrics: ... I need a hero I’m holding out for a hero ‘til the morning light He’s gotta be
Naltrexone therapy for Hailey-Hailey disease: Confirming my addiction to evidence-based medicine
By Warren R. Heymann, MD Aug. 28, 2017 Hailey-Hailey disease. Patient 1: erythematous-crusted plaques on the lower midback before radiation treatment. ... Credit: ... JAAD I was fascinated by a presentation at the recent World Congress of Pediatric Dermatology discussing improvement of epidermolysis bullosa wounds with topical CBD (cannabis) oil.
Laser focus
Dermatologist experts discuss the latest advances in laser technology and offer tips on how to navigate the research and acquisition process ... Feature ... By Allison Evans, assistant managing editor, April 1, 2021 For the new dermatologist moving from residency to practice, or the established dermatologist simply seeking a challenge,
Expanding your cosmetic services
In Practice ... Beth Santmyire-Rosenberger, MD, PhD, is the owner of Appalachian Spring Dermatology, PLLC, in Fairmont, West Virginia. ... By Victoria Houghton, managing editor, May 1, 2019 Dermatology World talks with Beth Santmyire-Rosenberger, MD, PhD, from Appalachian Spring Dermatology, PLLC, in Fairmont, West Virginia, about how to expand the
Tinea gone wild: The emergence of Trichophyton indotineae as a global phenomenon
By Warren R. Heymann, MD, FAAD May 24, 2023 Vol. 5, No. 21 "Well, Jane, it just goes to show you, it’s always something — if it’s not one thing, it’s another." – Gilda Radner (as Roseanne Roseannadanna) to Jane Curtin, ... Saturday Night Live Just as I quietly celebrated
Advances in therapy for the Cronkhite-Canada syndrome have increased survival: And that’s the way it is
By Warren R. Heymann, MD, FAAD Aug. 28, 2024 Vol. 6, No. 35 Part of the folklore at the Albert Einstein College of Medicine when I rotated as a fourth-year medical student in dermatology was that a prior resident made the correct diagnosis of Cronkhite-Canada syndrome (CCS). The constellation of
Shocking news: Heat shock protein inhibition finally enters the realm of dermatologic therapy
By Warren R. Heymann, MD, FAAD Oct. 23, 2024 Vol. 6, No. 43 Heat shock proteins (HSP) were serendipitously discovered by the brilliant Professor Ferruccio Ritossa in 1962 while studying nucleic acid synthesis in chromosomal puffs of ... Drosophila salivary glands. De Maio states, "Ritossa noticed something unexpected when cells
From "slugging" to snail mucin
Dermatologists discuss popular social media trends impacting the skin. ... Feature ... By Emily Margosian, Assistant Editor, October 1, 2023 Social media and the skin have a long history together. For over 15 years, social media has been an ever-growing presence in nearly all facets of life: politics, commerce —
Short anagen syndrome: The long and short of it
By Warren R. Heymann, MD, FAAD Feb. 7, 2024 Vol. 6, No. 6 Have you ever encountered a patient who says that their hair does not grow very much and that they rarely need to cut their hair? I have, and I suppose you have, too. Although considered uncommon, short
Cannabinoids may elevate therapy for connective tissue diseases to a higher level
By Warren R. Heymann, MD Nov. 2, 2017 Medical "reefer madness" is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of
PDF of psoriasis phototheraphy guideline treatment pathway
phototherapy or therapy or continue as therapy or continue as combination combination combination
PDF of psoriasis clinical pathways
Yes No Consider prescribing a topical Is the patient taking biologic, systemic (See topical therapy
PDF of Clinical guideline flowchart for treating psoriasis patients using systemic non-biologics
contraindications See supplementary table (3) for the list of possible adverse effects No Yes If the therapy
Checking in on the adverse reactions to checkpoint inhibitors
By Warren R. Heymann, MD Oct. 17, 2016 Earlier this year there have been two posts devoted to adverse reactions of checkpoint inhibitors ("Thinking of Discontinuing the PD-1 Inhibitor Because of a Lichenoid Eruption? Don’t do it!" published on May 21st and "Joining the Bullae Pulpit: PD-1 inhibitors" posted on
PDT for erosive pustular dermatitis of the scalp: Seeing the light (but reaching a different conclusion)
By Warren R. Heymann, MD June 9, 2016 Erosive Pustular Dermatitis of the Scalp (EPDS) is a relative common condition, typically seen on the actinically damaged scalps of the elderly men. Lesions characteristically present as hyperkeratotic, crusted erosions with varying degrees of pustulation. Lesions may become secondarily infected. The etiology
Beyond dermoscopy
Emergent technologies enhance imaging, target rare diseases. ... Feature ... By Jan Bowers, Contributing Writer, August 1, 2023 Dermoscopy has arrived. "While there are established practicing dermatologists who are not using it, it’s integrated across the residency programs," said Ashfaq A. Marghoob, MD, FAAD, attending physician at Memorial Sloan Kettering
Managing formulary changes
DermWorld looks at disruptive prescription coverage changes and offers tools for navigating these pain points. ... Feature ... By Amy Freed Stalzer, Contributing Writer, March 1, 2023 It’s not an uncommon scenario: A dermatologist refills a prescription for a patient but comes to find out that the patient’s insurance formulary
Vitiligo and melanoma: New thoughts on an old observation
By Warren R. Heymann, MD Nov. 27, 2016 I was fortunate that as a resident and fellow I had marvelous attending physicians who would offer their pearls of wisdom. As it is impossible to study every dictum, I would (usually) accept these viewpoints as "facts" and incorporate them into practice.
PDF of AAD-31
treating multiple visible or subclinical actinic keratosis (AK) lesions, applying field-directed therapy
PDF of Cutaneous squamous cell carcinoma staging, risk classification, and management
if nodes or ENE (+) curative RT not feasible ≤3cm, ENE (-) (+), +/- systemic therapy cSCC Primary Tumor
I never wanted chaperones — until now
By Warren R. Heymann, MD Sept. 25, 2019 Vol. 1, No. 29 My oldest brother George had just gotten his driver’s license — under no circumstances would my mother allow him to drive his date Ruth to the movies. George protested vehemently, but ultimately relented, with my mother sitting in
Navigating drug shortages and more: Strategies and solutions
Answers in Practice ... By Olivia Barry, Manager, Practice Management, February 1, 2024 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff explains how to navigate drugs shortages and more. Prescription drug shortages are a persistent and complex challenge across dermatology. What is the
PDF of Dermatologic adverse events
with anti-PD1/ tous-to-violaceous papules and initial dose disruption in immunotherapy dosing PD-L1 therapy
A plasma cell dyscrasia fable: AESOP and POEMS presenting concurrently
By Warren R. Heymann, MD Sept. 7, 2016 There is a moral to every fable. In this commentary, it is that VEGF (vascular endothelial growth factor) may have multiple cutaneous manifestations, even in the same patient. ... Rongioletti et al presented the case of a 70 year-old man with an
Adherence to acne treatments: Flipped sides of the coin for physicians and patients
By Warren R. Heymann, MD Dec. 6, 2016 It takes a motivated, dedicated patient to adhere to their prescribed acne regimen. According to Moradi Tuchayi et al, primary nonadherence occurs when the medication is not even started. This may be due to lack of knowledge, confusion about usage, a weak
What is the role of dietary fiber and probiotics on the microbiome and melanoma immunotherapy response?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, July 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Kelly Nelson, MD, FAAD,
Perspectives on peristomal pyoderma gangrenosum
By Warren R. Heymann, MD Oct. 28, 2016 Peristomal pyoderma gangrenosum (PPG) is a challenging problem, both physically and emotionally. The diagnosis may be delayed, often being mistaken for an irritant dermatitis or an infection. Barbosa et al have performed an extensive review of their experience in 44 patients
Shedding light on tumoral melanosis
By Warren R. Heymann, MD, FAAD Oct. 9, 2024 Vol. 6, No. 41 Tumoral melanosis (TM) is a worrisome and confounding lesion for dermatologists and dermatopathologists alike. TM presents as darkly pigmented macules, papules, or nodules mimicking the appearance of a melanoma. Most cases are associated with either partial or
Chipping away at patient access hurdles
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, February 1, 2019 Picture this: A sick patient comes in for your help. As an experienced dermatologist, you know exactly what to do and are confident your prescribed course
What's hot?
What's hot ... December 30, 2017 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Annie Chiu, MD ... Body contouring is not only in demand among patients but presents a unique challenge for physicians to achieve consistent
August 30, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 30, 2023 ... Does low-dose oral minoxidil improve hair density in traction alopecia? DermWorld Insights and Inquiries : A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma Methotrexate: Drug survival and predicative
Moving target
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists have good options for treating actinic keratosis, but price fluctuations make picking the highest value option difficult ... Dermatologists have good options for treating actinic keratosis, but price fluctuations make picking the highest value option difficult ...
September 11, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 11, 2024 ... Safety of low-dose oral minoxidil for hair loss in patients receiving antihypertensive medications DermWorld Insights and Inquiries : Atopic dermatitis hide and seek — The impending role
2021 Legislative Conference Overview of Asks
Step authority over a patient’s care therapy prevents physicians from prescribing drugs that will provide
Scarred by dogma: Revising recommendations for surgery and isotretinoin use
By Warren R. Heymann, MD Aug. 22, 2017 Severe acne. ... Credit: American Academy of Dermatology teaching slide ... I have had the privilege of prescribing isotretinoin since its release in 1982. Is there any other dermatologic medication that has benefited our patients so greatly? I’ve weathered every isotretinoin controversy
Keeping abreast of drug-induced cutaneous lupus
By Warren R. Heymann, MD, FAAD Aug. 4, 2021 Vol. 3, No. 31 Tom Hanks, as Commander Jim Lovell in the movie ... Apollo 13, lamented that the world was not watching their onboard video, compared to Neil Armstrong’s moon landing a year earlier. Reality dictates that the seminal breakthroughs
Why use AAD measures
What are the different types of measures for MIPS reporting? ... There are two different categories of quality measures for reporting: MIPS measures and QCDR measures. Both can be used for MIPS reporting. ... MIPS measures are measures that are approved by CMS to be included in the Quality Payment
November 1, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 1, 2023 ... Can oral nutraceuticals reduce isotretinoin side effects? DermWorld Insights and Inquiries : Exchanging plasma exchange for a novel approach — The potential of FcRn antagonists in dermatologic
PDF for Clinical Pathway for Management of AK
black box warning for cardiovascular and gastrointestinal side effects Tirbanibulin PHOTODYNAMIC THERAPY
March 17, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 17, 2021 ... COVID-19 in melanoma patients DermWorld Insights and Inquiries : Hoops and happiness — Having the courage to take a shot DermWorld Young Physician Focus : Forging ahead
Problematic in pregnancy?
Dermatologists discuss the safety of common dermatologic drugs in pregnant patients. ... Feature ... By Jan Bowers, Contributing Writer, June 1, 2023 Few mourned the end of the FDA’s pregnancy risk letter categories for prescription and biologic drug labeling in 2015. In addition to being an oversimplified distillation of available
A checkup on immune checkpoint inhibitor-induced subacute cutaneous lupus
By Warren R. Heymann, MD, FAAD March 15, 2023 Vol. 5, No. 11 Keeping up with the expanding indications and adverse reactions to immune checkpoint inhibitors (ICIs) can be a full-time job. These drugs are anti-neoplastic because of cytotoxic T-cell activation. ICIs include the anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) agent ipilimumab,
Treating metastatic melanoma: Understanding a brave new world
Acta Eruditorum ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jane Grant-Kels, MD, and Daniel Klufas,
Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?
By Warren R. Heymann, MD February 12, 2020 Vol. 2, No. 6 Although Y2K never amounted to much, a solitary case report that year changed the dynamic in treating a vexing problem — melanoma in situ of the lentigo maligna (LM) subtype. Ahmed and Berth Jones reported treating an 88-year
Impact Report — Spring 2021
Our focus is on supporting members, and we want to be sure to tell you what we are doing for you. So, in addition to the annual printed Impact Report that we sent you in April, we’re going to continue to check in with you through quarterly updates online. Welcome
PDF of prior authorization key terms/concepts for patients and practice staff
2) does it require step therapy or a prior authorization?
An appealing step closer to targeted topical therapies
By Warren R. Heymann, MD, FAAD April 5, 2023 Vol. 5, No. 14 Although advances in molecular genetics have revolutionized our understanding of the pathogenesis of disease, the road to developing topical therapies based on these discoveries is in its infancy. ... Healthy maintenance of our stratum corneum is essential
Actinic keratosis guideline
Actinic keratosis (AK), rough scaly patches that arise on chronically ultraviolet-exposed skin, is one of the most common conditions diagnosed and treated by dermatologists in the United States. This guideline addresses the management of actinic keratosis, providing evidence-based recommendations for treatment. ... Actinic keratosis guideline ... Access the full actinic
March is a strange month
From the Editor ... Dr. Schwarzenberger is the physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, March 1, 2021 Other than the AAD Annual meeting (sadly, canceled for the second year, courtesy of the ongoing COVID-19 pandemic), there’s usually not much to look forward to in March. Sure, we
Vitiligo or vitiligo-like lesions and PD1-inhibitors: Which is right?
By Warren R. Heymann, MD June 1, 2017 The following is a well-known staple of Jewish humor. I’ve heard it thousands of times, but it always makes me smile: ... In a small town in Russia, people brought their complaints to the Rabbi to settle their differences. One man purchased
Applying the 2021 E/M coding concepts in everyday practice – Part 2
In our ongoing efforts to help members navigate the E/M changes in a simplified and relatable manner in everyday practice, part two of the AADA’s clinical vignettes focuses on the application of the concepts necessary to support reporting a high level of number and complexity of problems addressed, data analyzed,
Links in the care chain
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists are key providers in multispecialty care of melanoma, serious skin disease ... Dermatologists are key providers in multispecialty care of melanoma, serious skin disease ... By Jan Bowers, contributing writer A diagnosis of advanced melanoma marks the
Applying the 2021 E/M coding concepts in everyday practice – Part 8
Part eight of the AADA’s clinical vignettes focuses on the application of coding concepts related to E/M encounters. These clinical vignettes continue those of part 7 in this series, demonstrating how a common dermatologic condition, actinic keratosis, can be classified under different categories of problem addressed during the encounter depending
Seeing red with dupilumab
By Warren R. Heymann, MD, FAAD March 1, 2023 Vol. 5, No. 9 Since its release in 2017, dupilumab (a fully humanized monoclonal antibody that blocks IL-4 and IL-13) has transformed the therapeutic landscape for managing atopic dermatitis (AD) and other eczematous disorders, bullous pemphigoid, Kimura disease, etc. when used
2024 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... Dec. 17 - DWI&I Holiday Greeting 2025 Dec. 11 - Idiopathic granulomatous mastitis joins the pantheon of erythema nodosum-associated disorders Dec. 4 - Darier disease is rough clinically and therapeutically. MEK inhibition may offer a smoother future
September 15, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 15, 2021 ... Worsening psoriasis after COVID-19 vaccination DermWorld Insights and Inquiries : Is ivermectin an old drug with new tricks? Frontal fibrosing alopecia and facial care products Biden administration
Yeast rising: Predicting the efficacy of candida antigen immunotherapy for warts
By Warren R. Heymann, MD Oct. 2, 2017 ... Numerous flat warts (verrucae plana) seen on upper extremities of patient with epidermodysplasia verruciformis. ... Credit: ... JAAD Perhaps I’m paranoid, but I always think that warts are laughing at me, or at least at whatever I throw at them —
Should merkel cell carcinoma patients receive adjuvant radiation following excision? My personal parallel story
By Warren R. Heymann, MD Sept. 17, 2016 I was 34 years old when I was diagnosed with a stage I seminoma. Following an orchiectomy, I was instructed to see the radiation oncologist (at the same institution) for adjuvant radiation. ... "Why are you here today Dr. Heymann?" the radiation
Toxicity of topical timolol for infantile hemangiomas in preterm infants: Size matters
By Warren R. Heymann, MD Aug. 13, 2016 I have been using topical timolol (0.5% gel) for the past few years for infants with infantile hemangiomas (IH) with reasonable success, but I am always nervous about prescribing it, as data on the degree of topical absorption remains to be defined.
PS-Patient Access to Affordable Treatments
AADA\ understands the need to manage the unpredictable and growing costs of health care, including therapy
Granulomatous cheilitis: Back to the Future
By Warren R. Heymann, MD, FAAD June 1, 2022 Vol. 4, No. 22 I opened my dermatology practice in 1985 — looking retrospectively, life was then both simpler and more complicated. It was the pre-computer era when patients paid their fee at the time of their visit, utilizing a peg-board
May 1, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 1, 2024 ... Consensus statements for the treatment of vitiligo in younger patients DermWorld Insights and Inquiries : Eyebrow-raising complications of microblading Role of low-dose oral minoxidil for treatment of
October 25, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 25, 2023 ... Efficacy of berdazimer gel for molluscum contagiosum clearance DermWorld Insights and Inquiries : A permanent addition to the list of transient neonatal dermatoses — Transient abdominal telangiectasia
My fair-weather therapeutic friends for alopecia areata
By Warren R. Heymann, MD April 25, 2017 Type C clinical pattern of alopecia. A, Patchy hair loss on a background of a diffuse hair loss with (B) occipital involvement in an ophiasis-like pattern. C, Biopsy specimen obtained from the vertex of the scalp. Histopathology of vertical sections shows an
Sky high
PBM tactics increase drug prices, lower patient access ... Feature ... By Ruth Carol, Contributing Writer, September 1, 2022 Last month, ... DermWorld discussed the role pharmacy benefits managers (PBMs) play in the drug distribution chain. This month, we will discuss some of the tactics PBMs use that are driving
Weighing the options
As biologic therapies expand indications to children and adolescents, what do dermatologists need to know about balancing the risks and benefits? ... Feature ... By Allison Evans, Assistant Managing Editor, February 1, 2023 Over the past five years, younger patients have steadily gained access to a range of FDA-approved targeted
Of every possible solution for elastosis perforans serpiginosa, fractional carbon dioxide laser may be the best
By Warren R. Heymann, MD Nov. 13, 2017 ... Elastosis perforans serpiginosa. Clinical presentation. ... Credit: ... JAAD My initial attraction to dermatology, which still offers great appeal, is the challenge and joy of differential diagnosis and clinical-pathologic correlation. I learned quickly, however, that patients don’t want to be interesting
Preventing and treating Trichophyton indotineae
Prevention ... Specific recommendations to prevent ... T. indotineae infection do not exist, but physicians can educate patients about strategies for ... preventing dermatophyte infections in general. ... Health care professionals should use ... Standard Precautions when caring for patients with possible tinea. ... Empiric treatment ... Because confirmatory testing
April 26, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 26, 2023 ... Paroxetine for refractory erythema of rosacea? DermWorld Insights and Inquiries : Demodectic eruptions — More than you mite have imagined Nonthermal atmospheric plasma for molluscum and verruca
Image of measure 410 flowchart
of age) receiving systemic therapy using the PGA, BSA, PASI, and/or DLQI meeting specified benchmarks
Epidermolysis bullosa: The need for novel topical care
By Warren R. Heymann, MD May 7, 2018 ... Blue-black macules and papules on the back of the neck within the scars of a patient with recessive dystrophic epidermolysis bullosa. ... Photo: ... JAAD The advances in epidermolysis bullosa (EB) have been spellbinding. There are now four well-defined forms of
Memories of pneumocystis pneumonia and thoughts of prophylaxis
By Warren R. Heymann, MD ... Nov. 27, 2017 ... A chest x-ray examination demonstrated a ground-glass appearance throughout the bilateral mid lung zones with sparing of the apices (Fig. 1). ... Credit: ... JAAD My childhood friend Alan was a rotating surgical resident at Methodist Hospital in Houston
JAKne is on the horizon
By Warren R. Heymann, MD, FAAD July 27, 2022 Vol. 4, No. 30 If you are like me, you have read much more about JAK inhibitors (JAKi) than have prescribed them. We are all on a learning curve. The rapid introduction of topical ruxolitinib (Opzelura), oral upadacitinib (Rinvoq), and abrocitinib
Tailor-made care
Go to AAD Home ... Go to AAD Home ... Menu ... Experts discuss the benefits of personalized treatment plans for patients with hidradenitis suppurativa ... Experts discuss the benefits of personalized treatment plans for patients with hidradenitis suppurativa ... By Jan Bowers, contributing writer Hidradenitis suppurativa (HS) was once
Cutaneous complications of immune checkpoint inhibitors
DermWorld highlights some of the common (and not-so-common) skin complications associated with ICIs and shares expert tips for management. ... Feature ... By Heidi Splete, Contributing Writer, March 1, 2024 Immune checkpoint inhibitors (ICIs) are a mainstay of immunotherapy for many cancer types — including breast, colon, liver, lung, skin,
An incisive approach to chronic paronychia: The square flap technique
By Warren R. Heymann, MD Aug. 2, 2016 I cannot begin to guess how many patients I have seen with chronic paronychia (CP) since I started my residency 36 years ago. I know precisely how many patients I have referred for surgical correction of CP — zero! The reason for
In the Know
The AMA and UHC Collaborate to Develop Social Determinant Diagnosis Codes ... Did you know that United Healthcare (UHC) and the American Medical Association (AMA) are proposing to develop 23 new ICD-10-CM diagnosis codes that address social barriers to care? ... Developed by UHC and endorsed by the AMA, they
September 8, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 8, 2021 ... A review of spironolactone for androgenetic alopecia DermWorld Insights and Inquiries : Alarming but benign – The enigma of acute hemorrhagic edema of infancy What are the
The ultimate prognosis of eosinophilic fasciitis may not be groovy
By Warren R. Heymann, MD Sept. 18, 2017 Presentation in March 2017 with diffuse hyperpigmented sclerodermoid lesions of the bilateral upper extremities with palpable fasciitis and tightening of the distal forearm muscles. ... Credit: ... JAAD My patients with eosinophilic fasciitis (EF, Shulman syndrome) have been fortunate. They have been
PDF of measure 410 flowchart
of age) receiving systemic therapy using the PGA, BSA, PASI, and/or DLQI meeting specified benchmarks
Find drug prices in your area
The cost of medications is a barrier for many patients, particularly those without insurance or those whose prescription is not covered by insurance. You can search for drug prices in your area by visiting ... GoodRx . ... Additional assistance ... There are also several programs available for patients to
No longer flailing with Flegel disease
By Warren R. Heymann, MD, FAAD April 19, 2023 Vol. 5, No. 16 I was a toddler in 1958 when Heinz Flegel described ... hyperkeratosis lenticularis perstans (HLP) a 50-year-old man with persistent lesions on his dorsal feet and lower extremities. (1) In the ensuing decades, other than the clinical
Isotretinoin and diabetes: Of familiarity and surprise
By Warren R. Heymann, MD, FAAD July 6, 2022 Vol. 4, No. 27 On a gloriously sparkling, warm spring afternoon in 2009 I sat with my family in the right field bleachers of the new Yankee Stadium as the Bronx Bombers took on the Phillies. I relished the expansive majesty
2024 quality measures for MIPS reporting
2025 QCDR measure specifications ... Access a spreadsheet of ... 2025 QCDR measure specifications . ... Access 2024 MIPS quality measures by clicking the links in the table below. Number ... Name ... Description ... MIPS 137 Melanoma: Continuity of Care – Recall System ... Percentage of patients, regardless of
2024 quality measures for MIPS reporting
2024 QCDR measure specifications ... Access a spreadsheet of ... 2024 QCDR measure specifications . Or access our full analysis of the ... 2024 MIPS measures most relevant to dermatologists. ... Access quality measures specifications for MIPS by clicking the links in the table below. You can also access 2023
PDF of Update in melanoma theories
Cell N/A IV Ex vivo expan- Refractory Anti-melanocyte side effects Often administered with lympho- Therapy
April 3
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 3, 2019 ... Can the elimination diet hurt pediatric atopic dermatitis patients? DW Insights and Inquiries : Tofacitinib – a JAK inhibitor of all trades Unity in dermatology starts with
Does he or doesn’t he? Only his oncologist knows for sure!
By Warren R. Heymann, MD July 17, 2017 Repigmented hair overlying melanoma in situ of scalp. Slowly darkening patch of previously white hair on superior scalp. ... Credit: ... JAAD I’m racking my brain wondering if I have ever seen a case of idiopathic facial aseptic granuloma (IFAG) — I
Progress for progressive multifocal leukoencephalopathy
By Warren R. Heymann, MD May 8, 2019 Vol. 1, No.9 Progressive multifocal leukoencephalopathy (PML) is a nightmare. For any dermatologist seeing patients with autoimmune diseases, HIV, lymphoproliferative disorders, or who are on immunosuppressive medications (azathioprine, chlorambucil, cyclophosphamide, glucocorticoids methotrexate, TNF inhibitors, and rituximab), PML is a "sword of Damocles,"
Putting muscle into isotretinoin laboratory testing isn’t chopped liver!
By Danielle M. DeHoratius, MD August 14, 2019 Vol. 1, No. 23 When I first became interested in dermatology during medical school, I started shadowing dermatologists. When prescribing isotretinoin all the physicians needed was a small yellow sticker. They could give patients months of medication at a time. I am
Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human skin cancer with at least 200,000 to 400,000 new cases of cSCC expected each year in the US. These evidence-based guidelines on the management of cSCC provide the most current information on biopsy techniques, histopathologic assessment, tumor
Basal cell carcinoma
Basal cell carcinoma (BCC) is the most common human skin cancer, comprising more than half of all non-melanoma skin cancer diagnoses, that affect more than 3 million Americans annually. These evidence-based guidelines for the management of BCC provide the most current information on widely accepted therapies, emerging treatments, staging, biopsy
Develop a nose for suspecting angiosarcoma
Angiosarcoma histopathology. Anastomosing dilated vessels, lined by crowded endothelial cells, extend between pre-existing collagen bundles. (Hematoxylin-eosin-saffron stain; original magnification: ×40.) ... Credit: ... JAAD By Warren R. Heymann, MD Nov. 12, 2018 Occasionally I read an article that disturbs me, because I know that I would miss the diagnosis, with
Erosive pustular dermatosis of the scalp must no longer be dermatology’s secret
By Warren R. Heymann, MD May 30, 2017 As dermatologists, we get used to discussing disorders that are foreign to other physicians. A typical story would be someone with classic notalgia paresthetica whose primary care physician does not believe that cervical arthritis is responsible for the maddening scapular pruritus. "My
OblIgEd to search for steroid-sparing agents in treating bullous pemphigoid
By Warren R. Heymann, MD ... Jan. 19, 2017 ... I’m always anxious to learn about alternative approaches for treating bullous pemphigoid (BP). Perhaps it’s my imagination, but most of my patients with BP are elderly, diabetic, hypertensive, and anticoagulated. It is impossible to prescribe rituximab out of the
Springtime is tick time
By Warren R. Heymann, MD April 27, 2017 Petechial eruption on palm of child with Rocky Mountain spotted fever. ... Credit: ... JAAD Oh, the majesty of spring’s rejuvenation — a bloom’s aroma, opening day’s first pitch, and romance in the air. For dermatologists, no one will write a
July 31
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 31, 2019 ... Academy and NPF release new psoriasis phototherapy guidelines DW Insights and Inquiries : A metabolic pathway that may allow dermatologists to run rings around porokeratoses Having trouble
2020 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... December 23 - 2020 holiday greeting December 16 - We’re in hot water! Vibrio vulnificus infections are heading north December 9 - Much ado about nothing in dermatopathology December 2 - Pigmented onychomatricoma: Avoid getting nailed by
PDF of ASPS23 Measure Specifications
older who underwent reconstruction after skin cancer resection who were prescribed opioid/narcotic therapy
What we have learned about E/M coding and reimbursement in 2021
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, manager, coding & reimbursement, April 1, 2021 Academy coding staff address important coding topics each month in Derm Coding Consult. ... Read more Derm Coding Consult articles . On Jan. 1, 2021, changes were implemented to
PDF of Academy interim guidance on the use of biologics during the COVID-19 pandemic.
Academy strongly recommends that patients should not stop their ongoing systemic immunosuppressive therapy
Academy HAIR Grants take off
AAD distributes another round of hair disorder research grants ... Feature ... By Matthew Walsh, Member Communications Specialist, October 1, 2022 Earlier this year, the AAD awarded seven Hair Loss and Alopecia Initiative in Research (HAIR) grants to dermatologists across the country to help fund their research of hair disorders
The neutrophil-to-lymphocyte ratio in cancer: Beauty in simplicity
By Warren R. Heymann, MD ... Sept. 29, 2016 ... The world was stunned and saddened on January 28th, 1986 when the Space Shuttle Challenger exploded. Six months later, during the meeting of the Rogers Commission analyzing the disaster, the famed physicist Richard Feynman demonstrated how O-rings lost their
Clinical pearls: DRESS syndrome
Management and therapy at the 2023 AAD hypersensitivity reaction with eosinophils activation and Management
Dyeing for a “new” topical agent for psoriasis? Think indigo
By Warren R. Heymann, MD April 9, 2018 Despite the magnificent revolution of biologics for psoriasis, topical agents remain the cornerstone of treatment, either alone, or in combination with phototherapy or systemic treatments. Patients clamor for "natural" products and are increasingly steroid phobic (please see "Countering Corticophobia with Assistance from
PDF of Chemotherapy specific cutaneous reactions
moisturizers with keratinolytic proper- Achilles tendons, and malleoli ties, and possible cessation of therapy
Tofacitinib: A JAK inhibitor of all trades
By Warren R. Heymann, MD April 3, 2019 Vol. 1, No. 4 The Janus kinase inhibitors are taking the dermatologic therapeutic world by storm — at least in the literature. By now, most dermatologists are familiar with studies that have demonstrated efficacy in alopecia areata, vitiligo, psoriasis, psoriatic arthritis, and
Stepping back from the abyss: A kinder, gentler variant of calciphylaxis
By Warren R. Heymann, MD March 16, 2017 My reaction to the diagnosis of calciphylaxis is Pavlovian — I automatically think about an end-stage renal insufficiency patient with an abysmal prognosis. Increasingly there are reports of nonuremic forms of the disease, where the prognosis may not be as bleak (*although
2025 AAD Annual Meeting Global Education Day | International Psoriasis Council Agenda
United States AGENDA 14:00 Welcome and Introduction Bruce Strober 14:10 The Impact of Psoriasis Therapy
PDF of Panniculitis
panniculitis Face, proximal Associated with Associated with chronic cutane- Lobular inflamma- Antimalarial therapy
PDF of Acquired keratodermas
to use, or medicinal to develop after PPKs or photodynamic dorsal hands and feet applications) therapy
Raising a toast to advances in treating alcohol-induced flushing
By Warren R. Heymann, MD November 11, 2020 Vol. 2, No. 45 Whether with pride or embarrassment, we have all blushed. Also known as flushing, the process is defined as a visible reddening of the skin accompanied by a sensation of warmth, characteristically affecting the face, ears, neck, and upper
Sweating over acquired idiopathic generalized anhidrosis
By Warren R. Heymann, MD, FAAD June 8, 2022 Vol. 4, No. 23 As I am composing this commentary, I find myself daydreaming about the warmth that will envelop the Delaware Valley later this week — it has been a long, cold, lonely COVID-19 winter. Rising temperatures mean outdoor exercise
March 20, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 20, 2024 ... Combination imiquimod and 5-FU for treating AKs DermWorld Insights and Inquiries : San Diego AAD musings Talking points: Benzene found in acne care products Safety of dermatologic
PD1 blockade: The next step for aggressive basal cell carcinomas?
By Warren R. Heymann, MD April 19, 2017 I was about to start the weekend, relishing that delightful TGIF feeling, with one final task — go through lab reports in my bin. My mood became morose when I read the follow-up letter about Sue (not her real name). She
July 29, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 29, 2020 ... COVID-19: The impact on employed dermatologists DW Insights and Inquiries: The profound dermatological manifestations of COVID-19 part VI — Going to the dogs Young Physician Focus :
The power of state advocacy
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, November 1, 2019 When you think of advocacy, what do you think of? Capitol Hill and Congress? CMS and the FDA? If so, you’re not wrong. Many facets
Tofacitinib for adolescent alopecia areata: Balancing the risk-benefit ratio
By Warren R. Heymann, MD Jan. 17, 2017 Alopecia areata with patient 4 after 2 months of treatment with 2% tofacitinib in VersaBase cream (A) and after 6 months of treatment with 2% tofacitinib in liposomal base (B). ... Credit: ... JAAD There has been acute interest in utilizing Janus
Sirolimus for microcystic lymphatic malformations: Caviar for frog spawn
By Warren R. Heymann, MD Jan. 23, 2017 Recently, our understanding of lymphatic malformations (LMs) has vastly expanded. Genetic advances have focused on the PI3K/AKT/mTOR pathway allowing the use of mTOR inhibitors for those lesions involved in this pathway. As noted in a previous post (Rapalogs for vascular lesions: Caveat
AR - Appropriate Use Criteria
making by defining when it is, or is not, acceptable to utilize/perform a specific procedure, test, or therapy
PDF of Quality measure ASPS21 documentation tips
ASPS 21: Continuation of Anticoagulation Therapy in the Office- based Setting for Reconstruction
Changing a long-standing habit
By Warren R. Heymann, MD April 16, 2016 Topical corticosteroid has no influence has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratosis (AK): A randomized clinical trial. ... This is a randomized controlled clinical trial of patients with multiple AK and
Treatment for Jennifer’s Crohn’s disease leads to a skin ulcer
A dermatologist diagnoses a surgery patient’s ulcer as pyoderma gangrenosum and coordinates with a gastroenterologist to treat the condition. ... Jennifer's story ... Jennifer Sariego – Horsham, Pennsylvania ... I’ve had Crohn’s disease since I was 10 years old. Five years ago, I had my colon removed and surgery to
Impact Report — Fall 2021
As we close out another successful year, the Academy is already looking ahead. Our work is not static or short term, but an enduring commitment to progress, built on the successes of the past, for each member and for dermatology at large. All our membership benefits and advocacy and patient
PDF of Fall 2021 DIR
-More commonly associated with anti-PD1/ PD-L1 therapy Vitiligo-like Eruption -Characterized by macules
Prior authorization audits and innovations: Are we finally reducing the (PA)in?
By Lorraine L. Rosamilia, MD, FAAD Aug. 9, 2023 Vol. 5, No. 32 There is little utility in defining prior authorization (PA) for prescription medications as it relates to the practice of dermatology, as each of us navigates this process and its stagnation every day. There have been several studies
What do the AAD's new non melanoma skin cancer guidelines say?
Acta Eruditorum ... Dr. Van Voorhees is the physician editor of ... Dermatology World . She interviews the author of a recent study each month. ... By Abby S. Van Voorhees, MD, February 1, 2018 In this month's Acta Eruditorum column, Physician Editor Abby S. Van Voorhees, MD, talks with
CMS Medicare Physician Fee Schedule Specialty Physician Cuts
Data also reflect that 38 percent of physical therapy owners/partners reported that revenue had decreased
A future therapeutic Harlequin Romance?
By Warren R. Heymann, MD Sept. 17, 2018 A neonate with harlequin ichthyosis on day 21 of life after 3 weeks of treatment with acitretin at 1 mg/kg/d. ... Credit: ... JAAD My fiancé Ronnie, then a pediatric resident, called me excitedly, asking for my opinion about a remarkable neonate
Technology-based encounters in dermatology
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, August 1, 2019 Test your knowledge: Technology-based encounters in dermatology ... Take the quiz to see if you're up
PDF of Supplementary tables for treating psoriasis patients with systemic non-biologics
non-biologic treatment of psoriasis Page 6-7 Table 4 Contraindications for non-biologic systemic therapy
A fact sheet on Medicare physician payment cuts from a coalition of physician and non-physician health care provider organizations.
Radiology -9% Dietitian Nutritionist -5% Pathology -9% Gastroenterology -5% Physical/Occupational Therapy
The pregnant pause in cutaneous lymphoma
By Jennifer Villasenor-Park, MD, FAAD Oct. 2, 2024 Vol. 6, No. 40 I first met Anne when she was 30 years old and was experiencing a significant flare of her mycosis fungoides. She had already lived with the disease for 18 years having been diagnosed at the age of 12
Is low-dose methotrexate associated with a higher risk of melanoma development?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, February 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Anita Wluka, PhD, FRACP,
Decomplexing plexiform neurofibromas
By Warren R. Heymann, MD Dec. 29, 2016 Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome. Diffuse
PDF of industry expert sessions for theater 2
topical-only treatment and considerations for transitioning patients from a topical to a systemic therapy
Thinking of discontinuing the PD-1 inhibitor because of a lichenoid eruption? Don’t do it!
By Warren R. Heymann, MD May 21, 2016 Immune checkpoint inhibitors have been the proverbial "game changers" in oncology, and offer hope (and a chance of survival) where none existed just a few years ago. ... Cutaneous manifestations are the most common adverse reactions to these drugs. Indeed, more than
Move over Lues: Graft-versus-host disease is the new mimicker king
By Warren R. Heymann, MD May 9, 2016 I have always been intrigued by graft-versus-host disease (GVH). I first learned of the disorder in my college immunology course when it was referred to as a cause of "runting syndrome" in mice. ... In the context of transplant recipients, classical features
Managing melasma
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists discuss new understandings of the pathogenesis of melasma and emerging treatments ... Dermatologists discuss new understandings of the pathogenesis of melasma and emerging treatments ... By Jan Bowers, contributing writer The emotional toll of melasma on patients
What’s new in treating actinic keratosis?
Dermatologists discuss how to balance the latest evidence, patient preferences, and clinical experience when treating AKs ... Feature ... By Allison Evans, Assistant Managing Editor, November 1, 2022 Actinic keratoses (AKs) are commonly diagnosed and treated by dermatologists. In fact, the National Ambulatory Medical Care Survey on outpatient medical care
December 6, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 6, 2023 ... iPLEDGE wins: FDA to implement AADA’s recommendations DermWorld Insights and Inquiries : Aquagenic pruritus and polycythemia vera: Still valid (and mysterious) after all these years Treatment access
PDF of Oral disease, part 2
ulcers, usually on the gingivae, weeks cessation of chemo- mucositis lateral tongue, or buccal mucosa. therapy
Early recognition of Rituximab-induced late onset neutropenia is essential
By Warren R. Heymann, MD, FAAD April 13, 2022 Vol. 4, No. 15 Rituximab is an anti-CD20 chimeric antibody directed against a surface transmembrane protein marker (CD20) expressed on B-cells during differentiation from pre B-cell until the plasma cell stage, involved in the maturation and activation of B cells. Approved
Using gene expression profiling to identify risk of melanoma metastasis
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 3, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Sancy Leachman, MD, PhD, about her
This month's news from across the specialty
What's hot ... December 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD Being a fan of the Cleveland Browns football team, I am very familiar with organizational dysfunction. It’s not
Cosmetic treatments
Key messages ... The results you see after any cosmetic treatment depend largely on the skills and training of the person performing the treatment. That’s why the American Academy of Dermatology urges patients considering a cosmetic treatment to choose a board-certified dermatologist to get optimal results and consider their overall
PDF of Directions in Residency Winter 2022
appropriate patients for Donald and Barbara How should a resident prepare for a course of systemic therapy
This month’s news from across the specialty
What’s hot ... August 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to
This month’s news from across the specialty
What’s hot ... April 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate,MD, FAAD Melasma is a phenotype of photodamage with a complex and multifaceted etiology involving UV radiation, visible light, hormones, and genetics,
This month's news from across the specialty
What's hot ... January 1, 2020 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... MALLORY ABATE, MD Is frontal fibrosing alopecia (FFA) really caused by sunscreen? A new ... JAAD article reviews the evidence. The rising
Finding Joy in pediatric phototherapy
By Warren R. Heymann, MD Aug. 28, 2019 Vol. 1, No. 25 This commentary is dedicated to Joy, a bright, rambunctious, delightful bundle of energy with (formerly) recalcitrant atopic dermatitis, who taught me a great deal about phototherapy in children. ... The cutaneous effects of ultraviolet (UV) light are by
Psoriatic alopecia and sebaceous glands: An unfinished symphony
By Warren R. Heymann, MD June 15, 2017 Psoriasis and alopecia after initiation of TNFi. A, Diffuse erythematous pustules on the upper back of patient 1. B, Severe alopecia with mild papules on scalp of patient 4. ... Credit: ... JAAD Every so often, patients with psoriasis would ask me
JAAD
Putting muscle into isotretinoin laboratory testing isn’t chopped liver! The newest frontier for biologics and psoriasis may be adherence Progress for progressive multifocal leukoencephalopathy A ‘pregnant pause’ is necessary before concluding on the obstetric risk of vitiligo Dermatologists cannot be lax about acquired cutis laxa Congenital juvenile xanthogranulomas: Born to
Joining forces
Go to AAD Home ... Go to AAD Home ... Menu ... Collaboration and diverse expertise strengthen clinical practice guidelines ... Collaboration and diverse expertise strengthen clinical practice guidelines ... By Jan Bowers, contributing writer Dermatologists look to the AAD’s clinical practice guidelines to serve as a roadmap for providing
Debridements
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, January 1, 2020 Test your knowledge: Debridements ... Take the quiz to see if you're up to date. ...
Applying the 2021 E/M coding concepts in everyday practice – Part 4
Part four of the AADA’s clinical vignettes focuses on the application of coding concepts related to E/M encounters. These clinical vignettes demonstrate how chronicity and severity impacts the level of service provided. Missed the previous articles? Review them at ... Derm Coding Consult . Clinical vignette 13 ... 17-year-old male
PDF of Drug interactions in dermatology, part 2
Additive Effects Cyclosporine Psoralens with UVA Increased risk of cuta- Use caution with light therapy
Rheumatoid vasculitis? Rule-out methotrexate-associated EBV
By Warren R. Heymann, MD June 19, 2016 Rheumatoid vasculitis (RV) is a serious complication of rheumatoid arthritis (RA) causing high morbidity and mortality, despite aggressive immunosuppressive treatment. The incidence appears to be decreasing, possibly due to the recognition of smoking as the most important contributory factor. Male patients with
Danazol for telomerase disorders: Prolonging the end — For chromosomes (yes), for dyskeratosis congenita (perhaps)
By Warren R. Heymann, MD May 18, 2016 Telomeres are located at the ends of chromosomes; they are repaired by telomerases. Shortening of telomeres leads to cell senescence, apoptosis, and chromosome instability. Male hormones have been used for decades to treat bone marrow failure and may have their effect by
Interfering with interferon Gamma: The mechanisms behind acquired resistance to PD-1 inhibitors for melanoma
By Warren R. Heymann, MD Sept. 4, 2016 Astounding major advances in targeted therapies for melanoma, most notably by PD-1 blockade, have given hope and life to patients with metastatic melanoma. Approximately 30 % of advanced melanoma patients experience tumor responses from checkpoint blockade monotherapy, with better clinical responses seen
Atopic dermatitis clinical guideline by American Academy of Dermatology
Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin disease that occurs most frequently in children but also affects many adults. The Academy is publishing a series of updates to the AD guidelines, originally published in 2014. You can see these updates below, or continue past them for the original guidelines.
Impact Report — Winter 2022
With the support of members like you, we are stepping up to meet the challenges of the specialty together. Even COVID-19 has not stopped us from raising the bar on our efforts to keep the specialty strong and your patients healthy and informed. This is the first anniversary of our
PS-Isotretinoin
The effectiveness of systemic isotretinoin therapy in the treatment of acne has been demonstrated in
PDF of Advanced and Immuno-therapies
monitoring with visits every 4-6 weeks at baseline, then every month for first six months of therapy
February 20
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / February 20, 2019 ... Biologics may help fight heart disease in psoriasis patients AAD mourns the passing of Richard L. Dobson, MD Feedback requested: AAD joint guideline for reconstruction after skin
PDF of Teratogenic medications and dermatology
Acitretin must not be used by patients who are pregnant or who intend to become pregnant during therapy
February 22, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 22, 2023 ... How effective are field treatments for actinic keratosis? DermWorld Insights and Inquiries : Saving face — The importance of recognizing facial discoid dermatosis A systematic review of
PDF of Cosmoceuticals
Dermatologic Therapy, 20(5), 330-342. 2. Bowe, W.P. & Pugliese S. (2014).
PDF of boards fodder mastocytosis review
anesthesia, SM patients should be moni- tored for 24 hours as delayed anaphylaxis may occur o Local therapy
August 26, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 26, 2020 ... Navigating immunosuppression during a pandemic: A guide for the dermatologist DW Insights and Inquiries : Topical tacrolimus topics Derm Coding Consult : Proposed Medicare fee schedule includes
Do tumor-infiltrating lymphocytes predict melanoma outcomes?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, November 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with John T. Vetto, MD,
New urticaria guidelines update antihistamine recommendations
Acta Eruditorum ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 1, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Diane Baker, MD, about a recent
Paraneoplastic Sarcoidosis? A Proposal to Revise and Rename the “Sarcoidosis-Lymphoma Syndrome”
By Warren R. Heymann, MD June 18, 2018 ... A 45-year-old woman with cutaneous sarcoidosis at (A) baseline before treatment and (B) with koebnerization after BBLT (560 nm filter at 20 J/cm2, pulse width 30 msec, 20°C cooling, 7-mm square spot size, repetition rate 10 Hz). ... Credit: ... JAAD
Moving in to first place: Antimalarials for treating generalized granuloma annulare
... By Warren R. Heymann, MD March 26, 2017 Localized granuloma annulare. Erythematous annular plaques may be singular (A) or multiple (B). Localized granuloma annulare may also present as papules coalescing into circular plaques (C). ... Credit: ... JAAD At a University of Pennsylvania Duhring Conference years ago, an
Change is inevitable
From the Editor ... Dr. Schwarzenberger is the physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, August 1, 2023 What drives change is often worth considering, and it’s interesting to see where change takes us. Change can occur simply as a byproduct of growth and innovation but can
Stiff skin syndrome: Hard in many ways
By Warren R. Heymann, MD July 4, 2016 Stiff skin syndrome (SSS) is a noninflammatory, fibrosing condition of the skin and fascia, often affecting the limb girdle region, notably the buttock and thighs, resulting in a lordotic posture. It may be accompanied by subtle hypertrichosis and hyperpigmentation. The course tends
Spot on! Lentigines in resolved psoriatic plaques
By Warren R. Heymann, MD Nov. 30, 2016 Having treated psoriatic patients throughout my career, there have been innumerable occasions where patients were concerned about pigmentary changes following successful treatment of the plaques. I have usually reassured them that these are postinflammatory pigmentary alterations that should abate with time. Recently,
A new chapter in vitiligo management
Recent advances in vitiligo treatment and research open doors for physicians and patients. ... Feature ... By Emily Margosian, Assistant Editor, March 1, 2024 Since the Bronze Age, humans have recorded cases of vitiligo — and attempted to cure it. ... "3,400 years ago, ancient Indian texts called the ...
Olmsted syndrome patients can finally put their foot down
By Warren R. Heymann, MD January 20, 2021 Vol. 3, No. 3 Reading Olmsted’s seminal paper entitled "Keratodermia Palmaris et Plantaris Congenitalis" is captivating reading on multiple levels. In that era of descriptive dermatology, there is an allure in how he differentiates his patient from keratodermas described by the giants
PDF of Raising the Dermatology Voice
This year, we had prior authorization, step therapy and other The AADA supports legislation that would
PDF of 2021 resolutions
AAD/A002 (A-21): Off-Label Use of Therapy Policy Proposed Motion: RESOLVED, the AADA confirms and
PDF of guideline pathway for psoriasis comborbities
: > 150 mg/dL adherence to for further assessment Fast ing HDL cholest erol levels: established therapy
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 15, 2023 ... Platelet-rich plasma vs. minoxidil in androgenetic alopecia treatment DermWorld Insights and Inquiries : The woolly culprit — Lanolin revealed as an uncommon cause of dermatitis on normal
PDF of Phototherapy
Apply reaction physical blocker Therapy protoporphyrin toaging, superficial ALA to entire tx area, Hyperpigmentation
Boards Fodder: Clinically relevant drugs interactions in dermatology
Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders, 2001: 848-871. 5.
July 7, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 7, 2021 ... OTC eczema products with high prevalence of potentially allergenic ingredients DermWorld Insights and Inquiries : Progress in pemphigus — Solidifying rituximab’s role Share your comments on the
The pachydermoperiostosis prostaglandin paradigm
By Warren R. Heymann, MD July 10, 2019 Vol. 1, No. 18 Prostaglandins were the rage when I started medical school in 1975; their role in inflammatory dermatoses was considered of paramount importance throughout my residency in the early 1980s. Hours were spent studying the transformation of arachidoinic acid to
Softening the blow of calcinosis cutis: The promise of intralesional sodium thiosulfate
By Warren R. Heymann, MD Oct. 12, 2017 ... Calcinosis cutis and pseudoxanthoma elasticum of central abdomen. Firm, erythematous nodules with focal areas of yellow chalky material centrally. ... Credit: ... JAAD I’m not sure what’s harder about calcinosis cutis (CC), the lesion itself or treating it. ... Calcinosis cutis
It’s been six months! Here’s what the Academy has done for you…
From the President ... Dr. Kaufmann served as Academy president from March 2022 to March 2023. ... By Mark Kaufmann, MD, FAAD, September 1, 2022 It feels like just yesterday that more than 15,000 of us attended the 2022 AAD Annual Meeting in Boston, and it’s hard to believe that
Atrophic tinea versicolor: Knowledge about its pathogenesis is hypertrophying
By Warren R. Heymann, MD April 12, 2017 In the entry "Atrophic Tinea Versicolor: More Than a Mirage" (April 22, 2016), I learned that the atrophic appearance of some cases of tinea versicolor is not just an optical illusion. The case of a 35-year-old man with depressed brown lesions on
PDF of psoriasis phototherapy guideline supplemental tables
Maintenance therapy protocol Is the patient satisfied with the treatment outcome?
PDF of Oral disease, part 1
Complex aphthosis may require therapy with oral colchi- cine, dapsone or thalidomide. irections in D
CMS finalizes and implements evaluation and management visit complexity HCPCS add-on code G2211
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, May 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . CMS has officially implemented the novel
Electronic consultations
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, July 1, 2019 Test your knowledge: Electronic consultations ... Take the quiz to see if you're up to date.
PDF of Stars of the Academy 2021
Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture In recognition
Idiopathic granulomatous mastitis joins the pantheon of erythema nodosum-associated disorders
By Warren R. Heymann, MD, FAAD Dec. 11, 2024 Vol. 6, No. 49 Patients often ask me, "Doctor, is my disease rare?" I’m never quite sure how to respond — while most patients are relieved to know that they are not alone ("misery loves company"), some relish the experience of
What are the updated guidelines of care for the management of primary cutaneous melanoma?
Acta Eruditorum ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, December 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Susan M. Swetter, MD, and Hensin
What's new in treating connective tissue disease
Dermatologists discuss the latest advances in treating cutaneous lupus, dermatomyositis, and systemic sclerosis. ... Feature ... By Allison Evans, Assistant Managing Editor, July 1, 2023 There are more than 200 disorders included within the term "connective tissue disease." Some of these disorders predominantly affect the skin or have skin-related implications,
Helpful tips on meeting with members of Congress and how to advocate and personally share the importance of the asks to you.
policy and hits on general ideas like Medicare physician payment affecting access to care and step therapy
PDF of specialty guidance 04/07/20
Is There a Role For Statin Therapy in Acute Viral Infections?
Preventing hair loss in breast cancer patients is very cool
By Warren R. Heymann, MD Feb. 15, 2017 Dramatic change in physical appearance before (A) and 1 month after (B) treatment with paclitaxel and carboplatin. ... Credit: ... JAAD The loss of my late aunt Millie to breast cancer was devastating; it was even harder to bear after learning that
Dupilumab and the dawn of the biologic era for atopic dermatitis
By Warren R. Heymann, MD Aug. 28, 2016 I have a list of patients with severe, recalcitrant atopic dermatitis (AD) eagerly awaiting the release of dupilumab. I first became aware of this biologic from the article by Beck et al, who noted that dupilumab, a fully humanized monoclonal antibody that
Creating pathways to navigate patient care
In June, the AAD released an update to its Guidelines of Care for the Management of Actinic Keratosis (AK) to reflect tirbanibulin research. ... The guideline update, published in ... JAAD , focuses on the strongly recommended use of tirbanibulin, a first-in-class microtubule inhibitor recently approved by the FDA to
For patients with erythropoietic protoporphyria the tide has come in
By Warren Heymann, MD May 12, 2021 Vol. 3, No. 19 Oct. 8, 2019, was an eventful day for patients with erythopoietic protoporphyria (EPP) in the United States, when the FDA announced its approval of afamelanotide (Scenesse). (1) The drug was first approved in Italy in 2010. (2) ... Patients
This month's news from across the specialty
What's hot ... September 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD The parable of the blind men and the elephant speaks to the limitations of an individual’s perception in
The newest frontier for biologics and psoriasis may be adherence
By Warren R. Heymann, MD June 19, 2019 Vol. 1, No. 15 My first job as an attending dermatologist was heading the psoriasis day care center at the Albert Einstein College of Medicine in 1983. The challenges of treating severe psoriasis with the Goeckerman regimen, PUVA, methotrexate, etc. made
Getting the GIST cutaneous hyperpigmentation disease
By Warren R. Heymann, MD Nov. 6, 2019 Vol. 1, No. 35 Gastrointestinal stromal tumors (GISTs) are mesenchymal malignancies arising from the interstitial cells of Cajal (cells that create bioelectrical slow wave potential, leading to smooth muscle contraction, thereby aiding peristalsis). GISTs were initially recognized by identification of KIT (CD117)
Alopecia areata incognita in Cronkhite-Canada syndrome suggests an autoimmune etiology – and that’s the way it is.
By Warren R. Heymann, MD Sept. 14, 2017 Cronkhite–Canada syndrome. A, Onycholysis. B, Alopecia. ... Credit: ... JAAD I have always been intrigued by the mysterious nature of the Cronkhite-Canada syndrome (CCS) — although I have considered the disorder in my differential diagnosis, I have never seen a case. ...
Determining the appropriate lesion destruction code — benign or premalignant
Derm Coding Consult ... By Tiffany McFarland, RHIT, Analyst, Coding & Reimbursement, April 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The correct designation of lesions as benign, premalignant, or malignant is important for coding
Expanding indications of the excimer laser for disorders of hypopigmentation: Equivocally seeing the light
By Warren R. Heymann, MD Aug. 31, 2016 The excimer laser is a reasonably effective modality for treating vitiligo. Other disorders of hypopigmentation, such as a nevus depigmentosus (ND), or post-inflammatory hypopigmentation (PIH) secondary to lichen striatus (LS) may be distressing to patients (or their parents). Is the excimer laser
Postmortem: AADA Legislative Conference
From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, FAAD, November 1, 2021 Postmortem : "examination of a dead body," or "process of evaluating success (or failure) of a project’s ability to meet its goals." Given that definition,
COVID-19 guidance from specialty medical societies
Is There a Role For Statin Therapy in Acute Viral Infections?
A watershed discovery for potential treatment of pseudoxanthoma elasticum
By Warren R. Heymann, MD Feb. 28, 2017 Pseudoxanthoma elasticum. A, Multiple and yellowish papules on the neck. B, Polarized light dermoscopy revealing multiple blotchy, yellowish areas alternating with prominent superficial linear vessels. ... Credit: ... JAAD We had the honor of presenting a family with pseudoxanthoma elasticum (PXE) at
Joining the “fold”: Squamous cell carcinoma complicating porokeratosis ptychotropica
By Warren R. Heymann, MD June 26, 2017 Coalescent erythematous papules involving bilateral buttocks. ... Credit: ... JAAD I know the variants of porokeratoses and can recite them as though I am the very model of a modern major general — Mibelli, linear, punctate, palmoplantar, DSAP, superficial disseminated, immunosuppression-related, and
Treating acrodermatitis continua of hallopeau in 2018? Try guselkumab!
By Warren R. Heymann, MD April 21, 2017 Acrodermatitis continua of Hallopeau (ACH) is a disorder well known to dermatologists, but absolutely mysterious to everyone else. It is now considered a localized form of pustular psoriasis of the digits that may be accompanied by onychodystrophy and osteolysis. ... In my
June
Issue ... June January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... How do we get dermatologic care to those who need it? What’s hot ... This month’s news from across the specialty Clinical Applications ...
Keeping pace
Life-changing advances and a multidisciplinary approach give new hope to patients with Merkel cell carcinoma ... Feature ... By Allison Evans, Assistant Managing Editor, November 1, 2021 When Paul Nghiem, MD, PhD, FAAD, first started treating patients with skin cancer almost 20 years ago, physicians had little understanding of how
Coming full circle (almost): Low dose oral minoxidil for alopecia
By Warren R. Heymann, MD, FAAD January 5, 2022 Vol. 4, No. 1 I presume that virtually every dermatologist reading this commentary has recommended topical minoxidil (TM) for their patients with androgenetic alopecia (AGA) and other alopecias (telogen effluvium, alopecia areata [AA], hair shaft abnormalities, and eyebrow hypotrichosis). I recall
Lightening the cutaneous and emotional burden of melasma: Cysteamine’s role
By Warren R. Heymann, MD, FAAD February 9, 2022 Vol. 4, No. 6 Melasma is a frustrating disorder for patients and practitioners alike. Facial gray-brown patches may cause psychosocial distress and embarrassment, thereby diminishing quality of life. (1) Melasma most frequently occurs in women with Fitzpatrick skin types III-VI with
Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?
By Warren R. Heymann, MD, FAAD December 8, 2021 Vol. 3, No. 48 Ask any dermatology resident what the first-line treatment is for infantile hemangiomas (IH) and you will get a matter-of-fact response — "propranolol" — as if this has been an entrenched fact for decades. Barely more than a
Insult to injury: COVID-19-associated mucormycosis
By Warren Heymann, MD June 9, 2021 Vol. 3, No. 23 As America unmasks this Memorial Day, COVID-19 is ravaging India. The scenes of desperation stemming from the overwhelmed heath system, poverty, and funeral pyres are almost unfathomable. In the midst of the devastation, doctors in India have observed an
Definitions for the medical decision-making elements terminology
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, manager, coding and reimbursement, February 1, 2021 Academy coding staff address important coding topics each month in Derm Coding Consult. ... Read more Derm Coding Consult articles . Beginning Jan. 1, 2021, the selection of office
Nonepidemic Kaposi sarcoma: The fifth dimension
By Warren R. Heymann, MD Oct. 16, 2019 Vol. 1, No. 32 ... For more than a century, since first described in 1872 by Moritz Kaposi* as "idiopathic multiple pigmented sarcoma," dermatologists focused on classical Kaposi sarcoma (KS) — violaceous patches, plaques, and tumors on the lower extremities of
Does the JAK inhibitor baricitinib raise the bar on treating lupus?
By Warren R. Heymann, MD Aug. 20, 2018 Cutaneous lupus in dermatomal distribution. Erythematous papules in a dermatomal distribution along the patient's left lower extremity. ... Credit: ... JAAD Undeniably, the JAK inhibitors have been at the forefront of advances in immunologically-based diseases, including alopecia areata, vitiligo, psoriasis, rheumatoid arthritis,
On the cusp of extraordinary advances in extramammary Paget disease
By Warren R. Heymann, MD May 27, 2020 Vol. 2, No. 21 I always include extramammary Paget disease (EMPD) and Bowen disease in my differential diagnosis of anogenital rashes for fear of missing them. It is good form to biopsy such lesions should they not respond to standard therapies for
Knuckling down on knuckle pads
By Warren R. Heymann, MD April 1, 2020 Vol. 2, No. 13 Today is April Fools’ Day. Thus far, 2020 has felt like April Fools’ Year. All of us are dealing with COVID-19, 24/7. During World War II, morale was lifted by the song "There’ll be bluebirds over the White
Men in the Twilight Zoon
By Warren R. Heymann, MD February 19, 2020 Vol. 2, No. 7 It is a dimension as vast as space and as timeless as infinity. It is the middle ground between light and shadow, between science and superstition, and it lies between the pit of man's fears and the summit
State law and teratogenic medications
Patient access to teratogenic medication may be impacted by state abortion access laws. The Academy has resources for members who prescribe teratogenic medications. ... Patient access to reproductive resources ... Do you have questions about changes to state laws since the Supreme Court decision overturning ... Roe v Wade? Do
PDF of AD guidelines on phototherapy supplement
Concomitant therapy aside from emollients was not allowed but rescue therapy with topical steroids was
January 8, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / January 8, 2025 ... Topical finasteride with minoxidil vs. topical minoxidil alone for male-pattern androgenic alopecia DermWorld Insights and Inquiries : The treatment of systemic juvenile xanthogranulomas matures Weight-loss drugs for
May 3, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 3, 2023 ... Oral oxybutyloride for hidradenitis suppurativa patients? DermWorld Insights and Inquiries : Necrobiosis lipoidica in a Wink Exposure to anesthesia and alopecia areata Do study authors accurately report
January 25, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 25, 2023 ... Is topical spironolactone effective for acne? DermWorld Insights and Inquiries : The ironclad promise of ferroptosis Topical lidocaine-prilocaine vs. ice packs for laser hair removal Efficacy of
August 17, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 17, 2022 ... Do dietary exclusions improve atopic dermatitis? DermWorld Insights and Inquiries : Promising therapeutic developments for cutaneous lupus erythematosus — Interfering with interferon Derm Coding Consult : Dermatology
February 9, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 9, 2022 ... Tinted sunscreens: A practical guide to counseling patients DermWorld Insights and Inquiries : Lightening the cutaneous and emotional burden of melasma — cysteamine’s role Nemolizumab plus topicals
What can dermatologists do to prevent squamous cell carcinoma in solid organ transplant recipients?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, January 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Anokhi Jambusaria, MD, FAAD,
Storytelling in advocacy
Ask the Expert ... By Victoria Houghton, Managing Editor, February 1, 2023 DermWorld ... spoke to Alex Gross, MD, FAAD, chair of the AADA State Policy Committee, about how to utilize personal stories with policymakers to make an advocacy impact. DermWorld: Tell us about your experience advocating on behalf of
Herpes zoster, immunosuppression, and vaccination: Far from a blistering pace
By Warren R. Heymann, MD July 5, 2016 Do you recognize the name Chris Gueffroy? He was the last person shot trying to escape from East Berlin, before the wall came down. I had long promised myself that I would get Zostavax when I turned 60. Now 61, I am
Mucho de Mucha-Habermann
By Warren R. Heymann, MD Dec. 19, 2016 As we approach interview season for our residency program, I try to think of some questions I haven’t asked before. I usually do not discuss dermatologic disorders per se, as I am more concerned about the interviewee as a person knowing how
Desquamative gingivitis: Sinking your teeth in miagnosis and management
By Warren R. Heymann, MD Jan. 7, 2017 Cycle of oral hygiene in desquamative gingivitis. ... Credit: ... JAAD Patients presenting with desquamative gingivitis (DG) are typically some of the most frustrated, aggravated patients I encounter. Frequently, they have not been adequately evaluated, are in pain, and are desperate for
Mindfulness for the patient and the dermatologist
By Warren R. Heymann, MD ... March 28, 2017 ... While meditation has been present for millennia, the concept of mindfulness has recently come into vogue. Conceptually, mindfulness aims to have a person focus their attention on the present moment by developing coping strategies, such as meditation or deep
Becker’s nevus: Mutations that shoulder responsibility
By Warren R. Heymann, MD Aug. 31, 2017 Systematized, bilateral Becker nevus with hypoplasia of left areola in 19-year-old man (Courtesy of Dr Carlos de la Torre, Pontevedra, Spain). ... Credit: ... JAAD My wife insisted I take a break from studying for the dermatology boards. ... "Warren, give it
Ustekinumab: A topic for atopics?
By Warren R. Heymann, MD Jan. 9, 2017 Atopic dermatitis patient shows drastic improvement at week 19 of ustekinumab treatment. ... Credit: ... JAAD If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer
December
Issue ... December January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... They never taught us how to fail What's hot ... This month's news from across the specialty Clinical Applications ... Does the burden of
Patient power
Technology amplifies the patient voice in advocacy groups ... Feature ... By Jan Bowers, Contributing Writer, February 1, 2022 In the early 20th century, when a diagnosis of cancer almost inevitably led to death, a group of 10 physicians and five laypeople launched the American Society for the Control of
Tarrying for tapinarof
By Warren R. Heymann, MD, FAAD January 12, 2022 Vol. 4, No. 2 Today we held our first round of interviews for our dermatology residency program for 2023. Meeting dermatology resident applicants is a delight — they are brilliant, engaging, and a source of pride for our discipline. We started
What's hot?
What's hot ... June 28, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... "SPF 30 or higher" is the classic, impulse response that we often give when asked about sunscreen recommendations. However,
Risk factors for herpes zoster: Age, immunosuppression, and…statins?
... By Warren R. Heymann, MD Jan. 25, 2017 When I started my residency 37 years ago, I never would have imagined that nearly four decades later, I would be baffled by patients and their rashes every day. When I’m stumped diagnostically, I admit it (to myself and the
Coding and documentation for hyperhidrosis
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, November 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Clear and concise documentation is essential
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I called a colleague the other day to discuss a patient What's hot ... This month's news from across the specialty Clinical Applications ...
January
Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... More unintended consequences What's hot ... This month's news from across the specialty Clinical Applications ... What is the economic burden of drug utilization
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... March is a strange month What's hot ... This month's news from across the specialty Clinical Applications ... What is the path forward for
PDF of AK guideline for comment
The ultimate judgment regarding the 41 propriety of any specific therapy must be made by the physician
February 28, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 28, 2024 ... Ciclosporin vs. methotrexate for young patients with atopic dermatitis DermWorld Insights and Inquiries : Taming toxic erythema of chemotherapy with high-dose vitamin D Moisturizing cream with 20%
November 8, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 8, 2023 ... Terbinafine for onychomycosis: Continuous- vs. pulse-dose DermWorld Insights and Inquiries : NSA (neutrophilic sebaceous adenitis) secrets revealed AAD releases updated guidelines for atopic dermatitis FDA approves secukinumab
February 23, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 23, 2022 ... Frontal fibrosing alopecia: The effects of sunscreens and moisturizers DermWorld Insights and Inquiries : The vexing verruciform xanthoma DermWorld Young Physician Focus : The patient experience —
April 13, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 13, 2022 ... Is there an association between isotretinoin and adverse neuropsychiatric outcomes? DermWorld Insights and Inquiries : Early recognition of rituximab-induced late onset neutropenia is essential 2022 Academy election
February 10, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 10, 2021 ... FDA clears device to improve cellulite DermWorld Insights and Inquiries: Leishmania episode 1a — attack of the clones Distance traveled: Dr. Lim’s diversity focus as Academy president
Your Dermatologist Knows media wins 2023
A key part of Your Dermatologist Knows is pitching stories to media outlets in hopes they’ll run news stories sharing information about the wide breadth of knowledge dermatologists have to their readership. We consider every new story published as a result of our pitches as a win, regardless of whether
GP - Production Policy for Advertising the Academy
It will not advocate therapy or procedures not widely accepted by the medical community. 2.
PDF of Ferringer optional letter
Dermatology faces many challenges: regulation, the pandemic, reimbursement, corporatization, step therapy
DW Insights & Inquiries
DWI&I Holiday Greeting 2025 On behalf of the editors and staff of DWI&I, I wish you and your loved ones a healthy, safe, and peaceful 2025 and beyond. ... Idiopathic granulomatous mastitis IGM should be considered in inflammatory dermatoses of the breast in women of reproductive age. There are an
'Stepping up' to off-label dosing of biologics
By David A. Wetter, MD, FAAD April 6, 2022 Vol. 4, No. 14 It is an exciting time to be a medical dermatologist, with the ongoing development of numerous safe and effective systemic treatments for several complex medical dermatologic diseases. For example, both the American and British guidelines for the
What's hot?
What's hot ... August 23, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Are you over-checking labs for your acne patients on isotretinoin? An article from the ... JAAD’ s Best of
Brentuximab vedotin update and the #MeToo saga of the Reed-Sternberg cell
By Warren R. Heymann, MD Jan. 1, 2018 Myxoinflammatory fibroblastic sarcoma. High-power view showing large Reed-Sternberg–like cells (A) and mitotic figures (B). ... Credit: ... JAAD There has been increasing dermatological literature about the use of brentuximab vedotin (BV) for a variety of CD30+ cutaneous lymphomas. The thrust of this
Not the usual suspects
Go to AAD Home ... Go to AAD Home ... Menu ... Drugs you never thought you’d use in dermatology ... Drugs you never thought you’d use in dermatology ... By Jan Bowers, contributing writer ... Young dermatologists quickly become familiar with mainstays of treatment such as antibiotics,
Darier disease is rough clinically and therapeutically. MEK inhibition may offer a smoother future
By Warren R. Heymann, MD, FAAD Dec. 4, 2024 Vol. 6, No. 48 Consultative medical dermatology is stressful because challenging patients come with high hopes. Usually, the referring dermatologist is thorough, thoughtful, and on-target diagnostically and therapeutically. The key is setting expectations — if the dermatosis is easily manageable, they
An old dog with a new trick: High dose intralesional steroids in hidradenitis suppurativa
By Warren R. Heymann, MD, FAAD February 2, 2022 Vol. 4, No. 5 Hidradenitis suppurativa (HS) is hitting its stride academically — deservedly so. In 2000 there were 2 publications about HS in the ... Journal of the American Academy of Dermatology ; in 2010, 9 manuscripts; and, in 2020,
PDF of the Academy position on electronic surface brachytherapy
a The Academy has issued a position statement on superficial radiation therapy.
December 11, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 11, 2024 ... Consensus guidelines for off-label use of oral minoxidil for hair loss DermWorld Insights and Inquiries : Idiopathic granulomatous mastitis joins the pantheon of erythema nodosum-associated disorders Diagnostic
February 14, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 14, 2024 ... Topical tofacitinib for lichen planopilaris, frontal fibrosing alopecia DermWorld Insights and Inquiries : Caveat mTOR revisited — Neurofibromatosis Risk factors for development of tinea pedis, onychomycosis Mpox
March 6, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 6, 2024 ... Benzyl benzoate vs. permethrin in treating scabies DermWorld Insights and Inquiries : Hemochromatosis — Beyond 50 shades of gray Oral acitretin plus topical triamcinolone vs. topical triamcinolone
February 8, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 8, 2023 ... A review of newer agents for alopecia areata DermWorld Insights and Inquiries : A surgeon’s primary intention is to reduce secondary infection CDC investigating possibility of treatment-resistant
June 1, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 1, 2022 ... What’s new in adult acne over the last two years? DermWorld Insights and Inquiries : Granulomatous cheilitis — Back to the Future Derm Coding Consult : Cigna’s
July 27, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 27, 2022 ... Facial hyperhidrosis: Botulinum toxin A injection vs. topical glycopyrrolate DermWorld Insights and Inquiries : JAKne is on the horizon Dupilumab for chronic prurigo, chronic idiopathic pruritus Safety
June 9, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 9, 2021 ... Merkel cell carcinoma survival by anatomic site DermWorld Insights and Inquiries: Insult to injury — COVID-19-associated mucormycosis Microneedling with topical therapies for melasma Photosensitivity reaction from benzodiazepines
July 17
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 17, 2019 ... Isotretinoin, depression, and suicide: What’s the connection? DW Insights and Inquiries : Should dermatologists be anti-antihistamine for atopic dermatitis? 2018 MIPS performance feedback, final score, and targeted
This month’s news from across the specialty
What’s hot ... May 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS, FAAD Researchers at the University of Virginia showed that ... utilization of telemedicine by pediatric specialists in one
Coming to an ICU Near You — Candida auris
By Warren R. Heymann, MD ... Nov. 30, 2017 ... I first became aware of Candida auris (C. auris) during my 96-year-old mother’s most recent hospitalization in New York for congestive heart failure. The infectious disease epidemiologist called to ask permission to swab my mother’s skin for the yeast,
Evaluation and management in 2021: Part 4
Cracking the code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, December 1, 2020 Jan. 1, 2021: A new structure for reporting office and other outpatient evaluation and management (E/M)
This month’s news from across the specialty
What’s hot ... August 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS, FAAD You have likely noticed an increase in online reviews of yourself and your practice over the last
Psoriasin: Its other meaning and implications
By Warren R. Heymann, MD May 28, 2018 Biologic processes are akin to world-class orchestras requiring precise coordination between the conductor and musicians. One miscue by either can spoil the performance. I am awed by how our bodies function magnificently in health. The orchestration of the panoply of proteins, enzymes,
Get your KICS on Route IL-6
By Warren R. Heymann, MD March 1, 2018 Hemophagocytic lymphohistiocytosis (HLH) is a syndrome caused by hypercytokinemia (notably Th1 cytokines — interferon-gamma, tumor necrosis factor-alpha, and IL-6). Clinical manifestations are dramatic, presenting as fever, hepatosplenomegaly, hemophagocytosis, and cytopenias. (See the addendum for diagnostic criteria of HLH). Primary forms of HLH
Is dyshidrosiform pemphigoid really anti-p200 pemphigoid?
By Warren R. Heymann, MD Aug. 20, 2016 Dyshidrosiform pemphigoid (DP) was initially reported in a 72 year-old man with large, tense bullae on the plantar aspect of his feet, with some lesions on an erythematous base. He also had an "ill-defined papular eruption" of the trunk and an erosion
Your Dermatologist Knows: Media wins
The media remains hungry for stories about skin health and to advance our ... Your Dermatologist Knows goals, the Academy works together with members of the Media Expert Team to pitch stories to traditional media and online outlets to ensure the message that board-certified dermatologists are the experts in skin,
Dermatology World Weekly
DermWorld Weekly is a brief, concise digest of the latest news, hand-picked by ... DW’s editorial team with analysis of why it matters to dermatologists. ... Each week editors review the landscape of health care news in ... DermWorld's core areas of practice management, policy, and patient care, and highlight
PDF of draft guideline on AD topical therapies
The ultimate judgment regarding the propriety 68 of any specific therapy must be made by the physician
PDF of Vaccines in dermatology
complement component deficiency, and eculi- In addition to this exposure and patients at 16-23 zumab therapy
Cellular neurothekeoma: A tribute to Barnhill and Mihm and a remembrance of Martin C. Mihm Jr., MD
By Warren R. Heymann, MD, FAAD Aug. 2, 2023 Vol. 5, No. 31 The profound sense of loss prompting people to endure waiting over 24 hours in a queue to pay their final respect to Queen Elizabeth II at Westminster Hall was an astonishing sight last year. The overwhelming majority
A single case report has the potential to change the world: Could JAK inhibition alter the trajectory of multicentric reticulohistiocytosis?
By Warren R. Heymann, MD, FAAD July 20, 2022 Vol. 4, No. 29 One of the joys of practicing in the Delaware Valley is participating in the Philadelphia Dermatological Society (PDS). The local institutions each provide superlative patient presentations and lectures — the range of case presentations is stunning. For
Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod
By Warren Heymann, MD June 2, 2021 Vol. 3, No. 22 Most astute medical dermatologists are aware of drug-induced pemphigus, but many (including myself) may not be as familiar with topical medications being the responsible culprits. This commentary will focus on imiquimod-induced pemphigus and pemphigus-like eruptions (PLE). ... My curiosity
What is the path forward for treating children with severe atopic dermatitis with dupilumab?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, March 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Amy Paller, MD, about her recent
Juvenile lichen sclerosus: A loss of innocence
By Warren R. Heymann, MD August 19, 2020 Vol. 2, No. 33 Juvenile lichen sclerosus (LS) is a difficult disorder — symptomatically, emotionally, diagnostically, and therapeutically. During my residency it was "common knowledge" that juvenile LS would abate by adolescence. I am always curious how such perceptions become dogma, only
PS-Electronic Surface Brachytherapy
service that is verified by an a The Academy has issued a position statement on superficial radiation therapy
PDF of Modifiers quick coder
procedure was (a) planned or anticipated; (b) more extensive than the original procedure; or (c) for therapy
When is this year’s AADA Legislative Conference and will the event be in person?
Asked and Answered ... August 1, 2022 The 2022 AADA Legislative Conference will take place Sept. 18-20, at the Conrad Hotel, in Washington, D.C. ... Do I need experience in health policy to attend? ... No. Attendees do not need to be experts on health policy, the legislative process, or
Army veteran encourages skin checks following melanoma diagnosis
Dermatologist aids fellow service-member in melanoma diagnosis and treatment. ... Vincent's story ... Vincent Boles, patient ... During my 33 years in the U.S. Army, I learned the importance of examining my skin regularly because of the high exposure to UV rays and radiation during deployments. ... I was diagnosed
Practice management licensing opportunities
Navigating the health care environment can be tricky and difficult to understand. We've designed our practice management content to provide practical, easy-to-understand tools and guidance to help in a variety of areas, including coding and reimbursement, and MIPS. ... Derm Coding Consult (DCC) For more than a decade, ... Derm
PDF of 2019 Advocacy priorities.
Innovative Medicines (SAIM) Coalition, helped enact laws in 19 states restricting the use of step therapy
Caveat mTOR revisited: Neurofibromatosis
By Warren R. Heymann, MD, FAAD Feb. 14, 2024 Vol. 6, No. 7 An abridged version of this commentary was published in "A Clinician's Perspective" in the April 2023 issue of the JAAD. ... It is understandable how dermatologists may forget about many details of rare genodermatoses after taking their
PDF of AAD-4
• Tumors in areas of previous radiation therapy.
September 27, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 27, 2023 ... Is roflumilast effective in patients with seborrheic dermatitis? DermWorld Insights and Inquiries : Diminishing diagnostic cognitive bias — Anchors away JAK inhibitors for granulomatous dermatoses Is there
November 30, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 30, 2022 ... Chemotherapeutics for treating actinic keratosis DermWorld Insights and Inquiries : Palmar Pagetoid dyskeratosis — A sheep in wolf’s clothing A guide to transitioning to JAK inhibitors for
February 16, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 16, 2022 ... A review of calcipotriol plus 5-fluorouracil for actinic keratosis DermWorld Insights and Inquiries : Vascular Ehlers-Danlos syndrome: From rupture to rapture? Delayed complications for FDA-approved HA dermal
October 9, 2019
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 9, 2019 ... Topical calcineurin inhibitors vs. topical corticosteroids for vitiligo DW Insights and Inquiries : Glucose monitors — Not as sweet as they seem American Board of Dermatology announces
August 25, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 25, 2021 ... TNF inhibitors vs. IL-17/IL-23 inhibitors for psoriasis and PsA DermWorld Insights and Inquiries : Immediate pathology report release to patients — Is the 21st Century CURES Act
August 11, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 11, 2021 ... Topical tofacitinib for alopecia areata affecting facial hair DermWorld Insights and Inquiries : Monitoring infantile hemangiomas — What’s the score? Is there an effective treatment for skin
February 12, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 12, 2020 ... FDA prioritizes drug shortages with new approval policy DW Insights and Inquiries : Twenty years of imiquimod taking its toll on lentigo maligna: Where are we? CMS
What’s new in the management of acne vulgaris?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, May 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with John Barbieri,
This month’s news from across the specialty
What’s hot ... March 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD New, but not new, but maybe new, but not good = ... Candida auris is looking worse with
Service animals in your office
Legally Speaking ... Clifford Warren Lober, MD, JD, presents legal dilemmas in dermatology every other month. He is a dermatologist in practice in Florida and a partner in the law firm Lober, Brown, and Lober. ... By Clifford Warren Lober, MD, JD, June 1, 2018 Avalon: Bryan, I just had
Guidelines for the management of hidradenitis suppurativa
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, August 1, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Christopher Sayed, MD, about his recent
Is there a best approach to widespread actinic keratoses?
By Deirdre Connolly, MD and Naomi Lawrence, MD April 10, 2019 Vol. 1, No. 5 Journal of the American Academy of Dermatology Volume 72, Issue 2, Pages e57-e59 (February 2015) ... Widespread actinic keratoses (AKs) are problematic to both patients and physicians, not only because of their pre-cancerous nature, but
The alphabetization of lymphomatoid papulosis: Focus on “F”
By Warren R. Heymann, MD April 3, 2017 Follicular lymphomatoid papulosis. Recurrent papulonodular lesions on face (A to C). Patient had similar lesions on extremities. ... Credit: ... JAAD Seven years ago, today (April 3rd, 2010) my wife purchased an iPad on its inaugural release date. The only choices to
Calcineurin inhibitors under occlusion – I could’ve had a V8!
By Warren R. Heymann, MD June 6, 2017 I have used topical steroids under occlusion for as long I have been in dermatology. What a fabulous maneuver this is for difficult to treat dermatoses such as lichen simplex chronicus, recalcitrant psoriasis, or hypertrophic lichen planus, etc. I recommend Saran wrap
2017’s management of Stevens-Johnson/toxic epidermal necrolysis: The pendulum is swinging
By Warren R. Heymann, MD Jan. 1, 2017 A, Sheet-like detachment, blisters, and raw erosions on back of patient with Stevens-Johnson syndrome/toxic epidermal necrolysis. B, Postinflammatory hyperpigmentation accentuated in areas where detached epidermis was not left in situ. ... Credit: ... JAAD As in any controversial subject, it is essential
Teprotumumab: An eye-opening advance for pretibial myxedema?
By Warren R. Heymann, MD May 8, 2017 Histologic images of PME. (A, Hematoxylin-eosin stain; original magnification, ×40. B, Colloidal iron stain; original magnification, ×100.) ... Credit: ... JAAD Having just completed the chapter on the treatment of pretibial myxedema (PTM, also known as thyroid dermopathy) for the upcoming
What regulatory changes are needed to improve safety and reduce complications of permanent makeup?
Clinical Applications ... Dr. Schwarzenberger is the physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, January 1, 2025 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Jack Newcomer,
Key messaging in social media about acne
Key messages ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (1)
Key messages about rosacea for social media
Key messages ... Rosacea is a common skin condition that mainly affects the face. You may see flushing, lasting color (red, violet, or brown), acne-like breakouts, or visible blood vessels. Some people develop irritated eyes or thickening skin. (1,2) ... Although there is no cure for rosacea, proper treatment can
American Academy of Dermatology issues updated guidelines for the management of atopic dermatitis in adults with topical therapies
Both well-established and newer topical treatments addressed ROSEMONT, Ill. (January 11, 2023) — Often called eczema or atopic eczema, atopic dermatitis is a common skin condition, affecting 1 in 10 Americans. Although atopic dermatitis occurs most frequently in children, it also affects adults and can have a significant impact on
2023 Global Education Day - International Eczema Council agenda
3:40 – 3:55 PM Refreshment Break 3:55 – 4:40 PM Management of PN including diagnosis and current therapy
2019 World Congress Fund Poster Abstract eBook
Especially, this therapy was more efficacious on the skin surgery or chemotherapy.
British Journal of Dermatology
The pachydermoperiostosis prostaglandin paradigm Tofacitinib: A JAK inhibitor of all trades Focusing attention on X-linked ichthyosis We’ve gotta recognize GATA2 deficiency Sirolumus’s merit for the Kasabach-Merritt phenomenon Aha! The iodide paradox now makes sense! Changing perceptions of pediatric mastocytosis A string of (clinical) pearls about drug-induced linear IgA disease Dupilumab’s
NIAID guidelines for food allergy
2017 NIAID Addendum Guidelines for the Prevention of Peanut Allergy in the United States ... View key messages from the 2017 guidelines and 2010 addendum guidelines for peanut allergy below. ... Key messages ... This update to the 2010 NIAID food allergy guidelines addresses the prevention of peanut allergy and
Fighting fungi
With increasing resistance to antifungal therapies, here’s what dermatologists need to know about managing dermatophytosis. ... Feature ... By Allison Evans, Assistant Managing Editor, June 1, 2024 A patient presents with widespread, pruritic, scaly, and erythematous plaques of what appears to be tinea corporis. It may be routine to prescribe
One size does not fit all
Dermatologists discuss considerations and complexities in caring for older adults with skin cancer. ... Feature ... By Allison Evans, Assistant Managing Editor, February 1, 2024 In the same way that children cannot be treated as little adults, older adults (65+ years old) cannot be treated the same as younger adults.
What's the fuss about fungus?
Dermatologist nail experts discuss the diagnosis and management of onychomycosis as well as increasing resistance to anti-fungal therapies. ... Feature ... By Allison Evans, Assistant Managing Editor, January 1, 2024 Onychomycosis (tinea unguium) represents the highest proportion of nail disorders seen in clinical practice. With long and often unappealing therapeutic
PDF of Vasculitides
Vasculitides Anna Chacon, MD Diagnosis Epidemiology Pathogenesis Clinical Diagnostic Pathology Therapy
The breathless complications of anti-MDA-5-positive dermatomyositis
By Warren R. Heymann, MD, FAAD Oct. 30, 2024 Vol. 6, No. 44 Dermatologists are familiar with the spectrum of dermatomyositis (DM) — classic DM, juvenile DM, amyopathic DM, and cancer-associated DM. Clinically, amyopathic DM is a form in which the patients typically develop characteristic cutaneous features of DM [heliotrope
Digging deeper into lupus erythematosus panniculitis
By Warren Heymann, MD May 5, 2021 Vol. 3, No. 18 Lupus erythematosus panniculitis (aka lupus erythematosus profundus, LEP) has a storied history. The famed clinician Harry Arnold noted that Kaposi (when he was Kohn) observed nodules in patients with lupus. (1) Debates and controversies ensued for decades, with many